BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID of Ligand PubChem SID of Ligand ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence PDB ID(s) of Target Chain UniProt (SwissProt) Recommended Name of Target Chain UniProt (SwissProt) Entry Name of Target Chain UniProt (SwissProt) Primary ID of Target Chain UniProt (SwissProt) Secondary ID(s) of Target Chain UniProt (SwissProt) Alternative ID(s) of Target Chain UniProt (TrEMBL) Submitted Name of Target Chain UniProt (TrEMBL) Entry Name of Target Chain UniProt (TrEMBL) Primary ID of Target Chain UniProt (TrEMBL) Secondary ID(s) of Target Chain UniProt (TrEMBL) Alternative ID(s) of Target Chain 44809 C[C@H](CCCNCCNc1ccnc2cc(Cl)ccc12)[C@H]1CCC2C3[C@@H](C[C@@H]4C[C@@H](CC[C@]4(C)C3C[C@H](OC(C)=O)[C@]12C)OC(C)=O)OC(C)=O InChI=1S/C41H58ClN3O6/c1-24(8-7-16-43-18-19-45-35-14-17-44-36-22-29(42)9-10-31(35)36)32-11-12-33-39-34(23-38(41(32,33)6)51-27(4)48)40(5)15-13-30(49-25(2)46)20-28(40)21-37(39)50-26(3)47/h9-10,14,17,22,24,28,30,32-34,37-39,43H,7-8,11-13,15-16,18-21,23H2,1-6H3,(H,44,45)/t24-,28+,30-,32-,33?,34?,37-,38+,39?,40+,41-/m1/s1 OIIVAUPRMHYHRI-GLYQTUQUSA-N 23296 (2S,5R,7S,9R,14R,15R,16S)-14-[(1R)-4-({2-[(7-chloroquinolin-4-yl)amino]ethyl}amino)-1-methylbutyl]-5,9-bis(acetyloxy)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-16-yl acetate::4-amino-7-chloroquinoline (ACQ)-based compound, 1::JMC514388 Compound 6 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 10000 7.3 37.00 C Curated from the literature by BindingDB 10.1021/jm800737y 10.7270/Q2CF9ND5 18637666 aid1798467 Solaja, BA; Opsenica, D; Smith, KS; Milhous, WK; Terzić, N; Opsenica, I; Burnett, JC; Nuss, J; Gussio, R; Bavari, S University of Belgrade http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23296 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23296&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 91896000 50091561 ZINC96308797 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 44810 COC(=O)CC[C@@H](C)[C@H]1CCC2C3[C@@H](C[C@@H]4C[C@H](CC[C@]4(C)C3C[C@H](OC(C)=O)[C@]12C)NCCNc1ccnc2cc(Cl)ccc12)OC(C)=O InChI=1S/C40H56ClN3O6/c1-23(7-12-37(47)48-6)30-10-11-31-38-32(22-36(40(30,31)5)50-25(3)46)39(4)15-13-28(19-26(39)20-35(38)49-24(2)45)42-17-18-44-33-14-16-43-34-21-27(41)8-9-29(33)34/h8-9,14,16,21,23,26,28,30-32,35-36,38,42H,7,10-13,15,17-20,22H2,1-6H3,(H,43,44)/t23-,26+,28+,30-,31?,32?,35-,36+,38?,39+,40-/m1/s1 KRNXBGIVMRDNEB-AHBJFESSSA-N 23297 4-amino-7-chloroquinoline (ACQ)-based compound, 2::JMC514388 Compound 7::methyl (4R)-4-[(2S,5S,7S,9R,14R,15R,16S)-5-({2-[(7-chloroquinolin-4-yl)amino]ethyl}amino)-9,16-bis(acetyloxy)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoate Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 17000 7.3 37.00 C Curated from the literature by BindingDB 10.1021/jm800737y 10.7270/Q2CF9ND5 18637666 aid1798467 Solaja, BA; Opsenica, D; Smith, KS; Milhous, WK; Terzić, N; Opsenica, I; Burnett, JC; Nuss, J; Gussio, R; Bavari, S University of Belgrade http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23297 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23297&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 91896001 50091562 ZINC49942627 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 44811 COC(=O)CC[C@@H](C)[C@H]1CCC2C3[C@@H](C[C@@H]4C[C@@H](CC[C@]4(C)C3C[C@H](OC(C)=O)[C@]12C)NCCNc1ccnc2cc(Cl)ccc12)OC(C)=O InChI=1S/C40H56ClN3O6/c1-23(7-12-37(47)48-6)30-10-11-31-38-32(22-36(40(30,31)5)50-25(3)46)39(4)15-13-28(19-26(39)20-35(38)49-24(2)45)42-17-18-44-33-14-16-43-34-21-27(41)8-9-29(33)34/h8-9,14,16,21,23,26,28,30-32,35-36,38,42H,7,10-13,15,17-20,22H2,1-6H3,(H,43,44)/t23-,26+,28-,30-,31?,32?,35-,36+,38?,39+,40-/m1/s1 KRNXBGIVMRDNEB-VIIPABMFSA-N 23298 4-amino-7-chloroquinoline (ACQ)-based compound, 3::JMC514388 Compound 8::methyl (4R)-4-[(2S,5R,7S,9R,14R,15R,16S)-5-({2-[(7-chloroquinolin-4-yl)amino]ethyl}amino)-9,16-bis(acetyloxy)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoate Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 7000 7.3 37.00 C Curated from the literature by BindingDB 10.1021/jm800737y 10.7270/Q2CF9ND5 18637666 aid1798467 Solaja, BA; Opsenica, D; Smith, KS; Milhous, WK; Terzić, N; Opsenica, I; Burnett, JC; Nuss, J; Gussio, R; Bavari, S University of Belgrade http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23298 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23298&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 91896002 50091563 ZINC49794050 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 44812 Clc1ccc2c(NCCCNCC34CC5CC(CC(C5)C3)C4)ccnc2c1 InChI=1S/C23H30ClN3/c24-19-2-3-20-21(4-7-27-22(20)11-19)26-6-1-5-25-15-23-12-16-8-17(13-23)10-18(9-16)14-23/h2-4,7,11,16-18,25H,1,5-6,8-10,12-15H2,(H,26,27) JPSMOGYAVYUWKI-UHFFFAOYSA-N 24724 (adamantan-1-ylmethyl)({3-[(7-chloroquinolin-4-yl)amino]propyl})amine::4-Aminoquinoline, 21 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 31980 7.3 37.00 C Curated from the literature by BindingDB 10.1021/jm800737y 10.7270/Q2CF9ND5 18637666 aid1798467 Solaja, BA; Opsenica, D; Smith, KS; Milhous, WK; Terzić, N; Opsenica, I; Burnett, JC; Nuss, J; Gussio, R; Bavari, S University of Belgrade http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24724 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=24724&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24950184 56269675 ZINC40405889 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 44813 Clc1ccc2c(NCCNCC34CC5CC(CC(C5)C3)C4)ccnc2c1 InChI=1S/C22H28ClN3/c23-18-1-2-19-20(3-4-25-21(19)10-18)26-6-5-24-14-22-11-15-7-16(12-22)9-17(8-15)13-22/h1-4,10,15-17,24H,5-9,11-14H2,(H,25,26) XROLUQWWPXRCJD-UHFFFAOYSA-N 24725 (adamantan-1-ylmethyl)({2-[(7-chloroquinolin-4-yl)amino]ethyl})amine::4-Aminoquinoline, 20 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 18920 7.3 37.00 C Curated from the literature by BindingDB 10.1021/jm800737y 10.7270/Q2CF9ND5 18637666 aid1798467 Solaja, BA; Opsenica, D; Smith, KS; Milhous, WK; Terzić, N; Opsenica, I; Burnett, JC; Nuss, J; Gussio, R; Bavari, S University of Belgrade http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24725 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=24725&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24950183 56269676 ZINC40875272 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 44814 Clc1ccc2c(NCCCNCCC34CC5CC(CC(C5)C3)C4)ccnc2c1 InChI=1S/C24H32ClN3/c25-20-2-3-21-22(4-8-28-23(21)13-20)27-7-1-6-26-9-5-24-14-17-10-18(15-24)12-19(11-17)16-24/h2-4,8,13,17-19,26H,1,5-7,9-12,14-16H2,(H,27,28) AAWSSVSJWJZZBJ-UHFFFAOYSA-N 24726 4-Aminoquinoline, 18::[2-(adamantan-1-yl)ethyl]({3-[(7-chloroquinolin-4-yl)amino]propyl})amine Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 50100 7.3 37.00 C Curated from the literature by BindingDB 10.1021/jm800737y 10.7270/Q2CF9ND5 18637666 aid1798467 Solaja, BA; Opsenica, D; Smith, KS; Milhous, WK; Terzić, N; Opsenica, I; Burnett, JC; Nuss, J; Gussio, R; Bavari, S University of Belgrade http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24726 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=24726&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24950181 56269677 ZINC40395090 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 44815 Clc1ccc2c(NCCNCCC34CC5CC(CC(C5)C3)C4)ccnc2c1 InChI=1S/C23H30ClN3/c24-19-1-2-20-21(3-5-26-22(20)12-19)27-8-7-25-6-4-23-13-16-9-17(14-23)11-18(10-16)15-23/h1-3,5,12,16-18,25H,4,6-11,13-15H2,(H,26,27) DSKRTOQMVNFNKL-UHFFFAOYSA-N 24727 4-Aminoquinoline, 17::[2-(adamantan-1-yl)ethyl]({2-[(7-chloroquinolin-4-yl)amino]ethyl})amine Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 11810 7.3 37.00 C Curated from the literature by BindingDB 10.1021/jm800737y 10.7270/Q2CF9ND5 18637666 aid1798467 Solaja, BA; Opsenica, D; Smith, KS; Milhous, WK; Terzić, N; Opsenica, I; Burnett, JC; Nuss, J; Gussio, R; Bavari, S University of Belgrade http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24727 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=24727&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24950016 56269678 ZINC40894803 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42397 Nc1ccnc2cc(Cl)ccc12 InChI=1S/C9H7ClN2/c10-6-1-2-7-8(11)3-4-12-9(7)5-6/h1-5H,(H2,11,12) NDRZSRWMMUGOBP-UHFFFAOYSA-N 23300 4-amino-7-chloroquinoline (ACQ)-based compound, 5::7-chloroquinolin-4-amine::CHEMBL44789 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 7.3 22.00 C Curated from the literature by BindingDB 10.1021/jm061446e 10.7270/Q2VQ3105 17417831 aid1798312 Burnett, JC; Opsenica, D; Sriraghavan, K; Panchal, RG; Ruthel, G; Hermone, AR; Nguyen, TL; Kenny, TA; Lane, DJ; McGrath, CF; Schmidt, JJ; Vennerstrom, JL; Gussio, R; Solaja, BA; Bavari, S National Cancer Institute at Frederick http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23300 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23300&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 94711 50091565 CHEMBL44789 ZINC00436635 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42398 NCCNc1ccnc2cc(Cl)ccc12 InChI=1S/C11H12ClN3/c12-8-1-2-9-10(15-6-4-13)3-5-14-11(9)7-8/h1-3,5,7H,4,6,13H2,(H,14,15) XBDASFGJHWAFFE-UHFFFAOYSA-N 23301 4-amino-7-chloroquinoline (ACQ)-based compound, 6::N-(2-aminoethyl)-7-chloroquinolin-4-amine Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 7.3 22.00 C Curated from the literature by BindingDB 10.1021/jm061446e 10.7270/Q2VQ3105 17417831 aid1798312 Burnett, JC; Opsenica, D; Sriraghavan, K; Panchal, RG; Ruthel, G; Hermone, AR; Nguyen, TL; Kenny, TA; Lane, DJ; McGrath, CF; Schmidt, JJ; Vennerstrom, JL; Gussio, R; Solaja, BA; Bavari, S National Cancer Institute at Frederick http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23301 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23301&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 221208 50091566 ZINC19508762 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42399 NCCCNc1ccnc2cc(Cl)ccc12 InChI=1S/C12H14ClN3/c13-9-2-3-10-11(15-6-1-5-14)4-7-16-12(10)8-9/h2-4,7-8H,1,5-6,14H2,(H,15,16) YXPOTYIIRALLPH-UHFFFAOYSA-N 23302 4-amino-7-chloroquinoline (ACQ)-based compound, 7::N-(3-aminopropyl)-7-chloroquinolin-4-amine Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 7.3 22.00 C Curated from the literature by BindingDB 10.1021/jm061446e 10.7270/Q2VQ3105 17417831 aid1798312 Burnett, JC; Opsenica, D; Sriraghavan, K; Panchal, RG; Ruthel, G; Hermone, AR; Nguyen, TL; Kenny, TA; Lane, DJ; McGrath, CF; Schmidt, JJ; Vennerstrom, JL; Gussio, R; Solaja, BA; Bavari, S National Cancer Institute at Frederick http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23302 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23302&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 245076 50091567 ZINC19509455 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42400 COC(=O)CC[C@@H](C)[C@H]1CCC2C3[C@@H](C[C@@H]4C[C@@H](CC[C@]4(C)C3C[C@H](OC(C)=O)[C@]12C)OC(C)=O)OC(C)=O InChI=1S/C31H48O8/c1-17(8-11-28(35)36-7)23-9-10-24-29-25(16-27(31(23,24)6)39-20(4)34)30(5)13-12-22(37-18(2)32)14-21(30)15-26(29)38-19(3)33/h17,21-27,29H,8-16H2,1-7H3/t17-,21+,22-,23-,24?,25?,26-,27+,29?,30+,31-/m1/s1 VTBGQCBIQJMJJZ-ILVKKJKLSA-N 23303 methyl (4R)-4-[(2S,5R,7S,9R,14R,15R,16S)-5,9,16-tris(acetyloxy)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoate::tris(acetyloxy)cholan-24-oate deriv., 8 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 7.3 22.00 C Curated from the literature by BindingDB 10.1021/jm061446e 10.7270/Q2VQ3105 17417831 aid1798312 Burnett, JC; Opsenica, D; Sriraghavan, K; Panchal, RG; Ruthel, G; Hermone, AR; Nguyen, TL; Kenny, TA; Lane, DJ; McGrath, CF; Schmidt, JJ; Vennerstrom, JL; Gussio, R; Solaja, BA; Bavari, S National Cancer Institute at Frederick http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23303 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23303&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 11834930 50091568 ZINC14980485 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42401 COC(=O)CC[C@@H](C)[C@H]1CCC2C3[C@@H](C[C@@H]4C[C@H](N)CC[C@]4(C)C3C[C@H](OC(C)=O)[C@]12C)OC(C)=O InChI=1S/C29H47NO6/c1-16(7-10-26(33)34-6)21-8-9-22-27-23(15-25(29(21,22)5)36-18(3)32)28(4)12-11-20(30)13-19(28)14-24(27)35-17(2)31/h16,19-25,27H,7-15,30H2,1-6H3/t16-,19+,20-,21-,22?,23?,24-,25+,27?,28+,29-/m1/s1 KMEVUGUDTNKZFC-WZCMRTGLSA-N 23304 bis(acetyloxy)-3-aminocholan-24-oate::bis(acetyloxy)-3-aminocholan-24-oate deriv., 9::methyl (4R)-4-[(2S,5R,7S,9R,14R,15R,16S)-5-amino-9,16-bis(acetyloxy)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoate Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 7.3 22.00 C Curated from the literature by BindingDB 10.1021/jm061446e 10.7270/Q2VQ3105 17417831 aid1798312 Burnett, JC; Opsenica, D; Sriraghavan, K; Panchal, RG; Ruthel, G; Hermone, AR; Nguyen, TL; Kenny, TA; Lane, DJ; McGrath, CF; Schmidt, JJ; Vennerstrom, JL; Gussio, R; Solaja, BA; Bavari, S National Cancer Institute at Frederick http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23304 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23304&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 91896003 50091569 ZINC14980497 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42402 COC(=O)CCC(C)[C@H]1CCC2C3[C@@H](C[C@@H]4C[C@@H](CC[C@]4(C)C3C[C@H](OC(C)=O)[C@]12C)OCCNc1ccnc2cc(Cl)ccc12)OC(C)=O InChI=1S/C40H55ClN2O7/c1-23(7-12-37(46)47-6)30-10-11-31-38-32(22-36(40(30,31)5)50-25(3)45)39(4)15-13-28(19-26(39)20-35(38)49-24(2)44)48-18-17-43-33-14-16-42-34-21-27(41)8-9-29(33)34/h8-9,14,16,21,23,26,28,30-32,35-36,38H,7,10-13,15,17-20,22H2,1-6H3,(H,42,43)/t23?,26-,28+,30+,31?,32?,35+,36-,38?,39-,40+/m0/s1 QZZJNRWXLCKHIO-GRXWNZESSA-N 23305 4-amino-7-chloroquinoline (ACQ)-based compound, 10::methyl (4R)-4-[(2S,5R,7S,9R,14R,15R,16S)-5-{2-[(7-chloroquinolin-4-yl)amino]ethoxy}-9,16-bis(acetyloxy)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoate Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 7.3 22.00 C Curated from the literature by BindingDB 10.1021/jm061446e 10.7270/Q2VQ3105 17417831 aid1798312 Burnett, JC; Opsenica, D; Sriraghavan, K; Panchal, RG; Ruthel, G; Hermone, AR; Nguyen, TL; Kenny, TA; Lane, DJ; McGrath, CF; Schmidt, JJ; Vennerstrom, JL; Gussio, R; Solaja, BA; Bavari, S National Cancer Institute at Frederick http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23305 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23305&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24860360 50091570 ZINC96308801 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42403 COC(=O)CC[C@@H](C)[C@H]1CCC2C3[C@@H](C[C@@H]4C[C@@H](CC[C@]4(C)C3C[C@H](OC(C)=O)[C@]12C)OCCNCCNc1ccnc2cc(Cl)ccc12)OC(C)=O InChI=1S/C42H60ClN3O7/c1-25(7-12-39(49)50-6)32-10-11-33-40-34(24-38(42(32,33)5)53-27(3)48)41(4)15-13-30(21-28(41)22-37(40)52-26(2)47)51-20-19-44-17-18-46-35-14-16-45-36-23-29(43)8-9-31(35)36/h8-9,14,16,23,25,28,30,32-34,37-38,40,44H,7,10-13,15,17-22,24H2,1-6H3,(H,45,46)/t25-,28+,30-,32-,33?,34?,37-,38+,40?,41+,42-/m1/s1 GUCBGTAYRRFARZ-PCCZYKRWSA-N 23306 4-amino-7-chloroquinoline (ACQ)-based compound, 11::methyl (4R)-4-[(2S,5R,7S,9R,14R,15R,16S)-5-[2-({2-[(7-chloroquinolin-4-yl)amino]ethyl}amino)ethoxy]-9,16-bis(acetyloxy)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoate Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 7.3 22.00 C Curated from the literature by BindingDB 10.1021/jm061446e 10.7270/Q2VQ3105 17417831 aid1798312 Burnett, JC; Opsenica, D; Sriraghavan, K; Panchal, RG; Ruthel, G; Hermone, AR; Nguyen, TL; Kenny, TA; Lane, DJ; McGrath, CF; Schmidt, JJ; Vennerstrom, JL; Gussio, R; Solaja, BA; Bavari, S National Cancer Institute at Frederick http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23306 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23306&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 91896004 50091571 ZINC96308805 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42355 Oc1ccc(CCNC(=O)CN(CC(=O)NCc2cc(F)cc(c2)C(F)(F)F)C(=O)Cn2c(cc3ccccc23)C(=O)N[C@H]2CCCC[C@@H]2NC(=O)c2cc3ccccc3n2CC(=O)N(CC(=O)NCCc2ccc(O)cc2)CC(=O)NCc2cc(F)cc(c2)C(F)(F)F)cc1 InChI=1S/C68H66F8N10O10/c69-49-27-43(25-47(31-49)67(71,72)73)33-79-61(91)37-83(35-59(89)77-23-21-41-13-17-51(87)18-14-41)63(93)39-85-55-11-5-1-7-45(55)29-57(85)65(95)81-53-9-3-4-10-54(53)82-66(96)58-30-46-8-2-6-12-56(46)86(58)40-64(94)84(36-60(90)78-24-22-42-15-19-52(88)20-16-42)38-62(92)80-34-44-26-48(68(74,75)76)32-50(70)28-44/h1-2,5-8,11-20,25-32,53-54,87-88H,3-4,9-10,21-24,33-40H2,(H,77,89)(H,78,90)(H,79,91)(H,80,92)(H,81,95)(H,82,96)/t53-,54-/m0/s1 WFMNDOBQCAQRGQ-PJYGOTMFSA-N 23259 1-({[({[3-fluoro-5-(trifluoromethyl)phenyl]methyl}carbamoyl)methyl]({[2-(4-hydroxyphenyl)ethyl]carbamoyl}methyl)carbamoyl}methyl)-N-[(1S,2S)-2-{[1-({[({[3-fluoro-5-(trifluoromethyl)phenyl]methyl}carbamoyl)methyl]({[2-(4-hydroxyphenyl)ethyl]carbamoyl}methyl)carbamoyl}methyl)-1H-indole-2-]amido}cyclohexyl]-1H-indole-2-carboxamide::HD4-A3B5 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 14300 7.4 23.00 C Curated from the literature by BindingDB 10.1073/pnas.0611213104 10.7270/Q28050WN 17293454 aid1798309 Eubanks, LM; Hixon, MS; Jin, W; Hong, S; Clancy, CM; Tepp, WH; Baldwin, MR; Malizio, CJ; Goodnough, MC; Barbieri, JT; Johnson, EA; Boger, DL; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23259&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24860332 50091524 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42356 COc1ccc(CCNC(=O)CN(CC(=O)NC2CC2c2ccccc2)C(=O)Cn2c(cc3ccccc23)C(=O)N[C@H]2CCCC[C@@H]2NC(=O)c2cc3ccccc3n2CC(=O)N(CC(=O)NCCc2ccc(OC)cc2)CC(=O)NC2CC2c2ccccc2)cc1 InChI=1S/C72H78N10O10/c1-91-53-29-25-47(26-30-53)33-35-73-65(83)41-79(43-67(85)75-59-39-55(59)49-15-5-3-6-16-49)69(87)45-81-61-23-13-9-19-51(61)37-63(81)71(89)77-57-21-11-12-22-58(57)78-72(90)64-38-52-20-10-14-24-62(52)82(64)46-70(88)80(42-66(84)74-36-34-48-27-31-54(92-2)32-28-48)44-68(86)76-60-40-56(60)50-17-7-4-8-18-50/h3-10,13-20,23-32,37-38,55-60H,11-12,21-22,33-36,39-46H2,1-2H3,(H,73,83)(H,74,84)(H,75,85)(H,76,86)(H,77,89)(H,78,90)/t55?,56?,57-,58-,59?,60?/m0/s1 YTEIZMXKEXGRIQ-CHPIPRIRSA-N 23260 1-{[({[2-(4-methoxyphenyl)ethyl]carbamoyl}methyl)({[(2-phenylcyclopropyl)carbamoyl]methyl})carbamoyl]methyl}-N-[(1S,2S)-2-[(1-{[({[2-(4-methoxyphenyl)ethyl]carbamoyl}methyl)({[(2-phenylcyclopropyl)carbamoyl]methyl})carbamoyl]methyl}-1H-indole-2-)amido]cyclohexyl]-1H-indole-2-carboxamide::HD4-A2B7 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 7600 7.4 23.00 C Curated from the literature by BindingDB 10.1073/pnas.0611213104 10.7270/Q28050WN 17293454 aid1798309 Eubanks, LM; Hixon, MS; Jin, W; Hong, S; Clancy, CM; Tepp, WH; Baldwin, MR; Malizio, CJ; Goodnough, MC; Barbieri, JT; Johnson, EA; Boger, DL; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23260 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23260&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24860333 50091525 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42357 COc1cccc(CCNC(=O)CN(CC(=O)NC2CCCc3ccccc23)C(=O)Cn2c(cc3ccccc23)C(=O)N[C@H]2CCCC[C@@H]2NC(=O)c2cc3ccccc3n2CC(=O)N(CC(=O)NCCc2cccc(OC)c2)CC(=O)NC2CCCc3ccccc23)c1 InChI=1S/C74H82N10O10/c1-93-55-25-13-17-49(39-55)35-37-75-67(85)43-81(45-69(87)77-59-31-15-23-51-19-3-7-27-57(51)59)71(89)47-83-63-33-11-5-21-53(63)41-65(83)73(91)79-61-29-9-10-30-62(61)80-74(92)66-42-54-22-6-12-34-64(54)84(66)48-72(90)82(44-68(86)76-38-36-50-18-14-26-56(40-50)94-2)46-70(88)78-60-32-16-24-52-20-4-8-28-58(52)60/h3-8,11-14,17-22,25-28,33-34,39-42,59-62H,9-10,15-16,23-24,29-32,35-38,43-48H2,1-2H3,(H,75,85)(H,76,86)(H,77,87)(H,78,88)(H,79,91)(H,80,92)/t59?,60?,61-,62-/m0/s1 RTRSXUBINBYSBH-HIOJUVKOSA-N 23261 1-{[({[2-(3-methoxyphenyl)ethyl]carbamoyl}methyl)[(1,2,3,4-tetrahydronaphthalen-1-ylcarbamoyl)methyl]carbamoyl]methyl}-N-[(1S,2S)-2-[(1-{[({[2-(3-methoxyphenyl)ethyl]carbamoyl}methyl)[(1,2,3,4-tetrahydronaphthalen-1-ylcarbamoyl)methyl]carbamoyl]methyl}-1H-indole-2-)amido]cyclohexyl]-1H-indole-2-carboxamide::HD4-A4B2 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 19100 7.4 23.00 C Curated from the literature by BindingDB 10.1073/pnas.0611213104 10.7270/Q28050WN 17293454 aid1798309 Eubanks, LM; Hixon, MS; Jin, W; Hong, S; Clancy, CM; Tepp, WH; Baldwin, MR; Malizio, CJ; Goodnough, MC; Barbieri, JT; Johnson, EA; Boger, DL; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23261&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24860334 50091526 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42358 COC(=O)c1cc2c3CCN(C(=O)c4nc5ccc(NC(=O)c6cc(NC(=O)OC(C)(C)C)cs6)cc5o4)c3ccc2[nH]1 InChI=1S/C30H27N5O7S/c1-30(2,3)42-29(39)32-16-12-24(43-14-16)25(36)31-15-5-6-20-23(11-15)41-26(34-20)27(37)35-10-9-17-18-13-21(28(38)40-4)33-19(18)7-8-22(17)35/h5-8,11-14,33H,9-10H2,1-4H3,(H,31,36)(H,32,39) YPLQZIMZZUUUAE-UHFFFAOYSA-N 23262 BDIS-A4B11C7::methyl 10-({6-[(4-{[(tert-butoxy)carbonyl]amino}thiophene-2-)amido]-1,3-benzoxazol-2-yl}carbonyl)-5,10-diazatricyclo[7.3.0.0^{2,6}]dodeca-1(9),2(6),3,7-tetraene-4-carboxylate Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 46200 7.4 23.00 C Curated from the literature by BindingDB 10.1073/pnas.0611213104 10.7270/Q28050WN 17293454 aid1798309 Eubanks, LM; Hixon, MS; Jin, W; Hong, S; Clancy, CM; Tepp, WH; Baldwin, MR; Malizio, CJ; Goodnough, MC; Barbieri, JT; Johnson, EA; Boger, DL; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23262 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23262&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24860335 50091527 ZINC14980393 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42359 O=C(NCCc1ccccc1)[C@H]1CN(C[C@@H]1C(=O)NC(c1ccccc1)c1ccccc1)C(=O)c1ccc(cc1)-c1ccc(cc1)C(=O)N1C[C@H]([C@@H](C1)C(=O)NC(c1ccccc1)c1ccccc1)C(=O)NCCc1ccccc1 InChI=1S/C68H64N6O6/c75-63(69-41-39-47-19-7-1-8-20-47)57-43-73(45-59(57)65(77)71-61(51-23-11-3-12-24-51)52-25-13-4-14-26-52)67(79)55-35-31-49(32-36-55)50-33-37-56(38-34-50)68(80)74-44-58(64(76)70-42-40-48-21-9-2-10-22-48)60(46-74)66(78)72-62(53-27-15-5-16-28-53)54-29-17-6-18-30-54/h1-38,57-62H,39-46H2,(H,69,75)(H,70,76)(H,71,77)(H,72,78)/t57-,58+,59-,60+ GBAWCFICERFORA-PFLBOCSKSA-N 23263 (3R,4R)-3-N-(diphenylmethyl)-1-{[4-(4-{[(3S,4S)-3-[(diphenylmethyl)carbamoyl]-4-[(2-phenylethyl)carbamoyl]pyrrolidin-1-yl]carbonyl}phenyl)phenyl]carbonyl}-4-N-(2-phenylethyl)pyrrolidine-3,4-dicarboxamide::TransPyr1-A1B6C6 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 54200 7.4 23.00 C Curated from the literature by BindingDB 10.1073/pnas.0611213104 10.7270/Q28050WN 17293454 aid1798309 Eubanks, LM; Hixon, MS; Jin, W; Hong, S; Clancy, CM; Tepp, WH; Baldwin, MR; Malizio, CJ; Goodnough, MC; Barbieri, JT; Johnson, EA; Boger, DL; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23263&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24860336 50091528 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42360 O=C(NCc1ccccc1)[C@H]1CN(C[C@@H]1C(=O)NC1C[C@@H]1c1ccccc1)C(=O)c1ccc(cc1)-c1ccc(cc1)C(=O)N1C[C@H]([C@@H](C1)C(=O)NC1C[C@H]1c1ccccc1)C(=O)NCc1ccccc1 InChI=1S/C58H56N6O6/c65-53(59-31-37-13-5-1-6-14-37)47-33-63(35-49(47)55(67)61-51-29-45(51)41-17-9-3-10-18-41)57(69)43-25-21-39(22-26-43)40-23-27-44(28-24-40)58(70)64-34-48(54(66)60-32-38-15-7-2-8-16-38)50(36-64)56(68)62-52-30-46(52)42-19-11-4-12-20-42/h1-28,45-52H,29-36H2,(H,59,65)(H,60,66)(H,61,67)(H,62,68)/t45-,46+,47+,48-,49+,50-,51?,52? IYWVOHJYPMCYKS-RNUAKSDQSA-N 23264 (3R,4R)-3-N-benzyl-1-{[4-(4-{[(3S,4S)-3-(benzylcarbamoyl)-4-{[(2S)-2-phenylcyclopropyl]carbamoyl}pyrrolidin-1-yl]carbonyl}phenyl)phenyl]carbonyl}-4-N-[(2R)-2-phenylcyclopropyl]pyrrolidine-3,4-dicarboxamide::TransPyr1-A6B9C6 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 91200 7.4 23.00 C Curated from the literature by BindingDB 10.1073/pnas.0611213104 10.7270/Q28050WN 17293454 aid1798309 Eubanks, LM; Hixon, MS; Jin, W; Hong, S; Clancy, CM; Tepp, WH; Baldwin, MR; Malizio, CJ; Goodnough, MC; Barbieri, JT; Johnson, EA; Boger, DL; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23264&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24860337 50091529 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42361 CCC1CN(CC(=O)N1Cc1ccc(C)cc1)C(=O)C=Cc1ccccc1 InChI=1S/C23H26N2O2/c1-3-21-16-24(22(26)14-13-19-7-5-4-6-8-19)17-23(27)25(21)15-20-11-9-18(2)10-12-20/h4-14,21H,3,15-17H2,1-2H3 SQNBKNGZQHNTGX-UHFFFAOYSA-N 23265 6-ethyl-1-[(4-methylphenyl)methyl]-4-[(2E)-3-phenylprop-2-enoyl]piperazin-2-one::NA-A1B2C10 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 12500 7.4 23.00 C Curated from the literature by BindingDB 10.1073/pnas.0611213104 10.7270/Q28050WN 17293454 aid1798309 Eubanks, LM; Hixon, MS; Jin, W; Hong, S; Clancy, CM; Tepp, WH; Baldwin, MR; Malizio, CJ; Goodnough, MC; Barbieri, JT; Johnson, EA; Boger, DL; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23265 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23265&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 16061867 50091530 ZINC14980398 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42362 ONC(=O)\C=C\c1ccc(cc1)C#N InChI=1S/C10H8N2O2/c11-7-9-3-1-8(2-4-9)5-6-10(13)12-14/h1-6,14H,(H,12,13)/b6-5+ JWSBMMPNUFYIFL-AATRIKPKSA-N 23266 (2E)-3-(4-cyanophenyl)-N-hydroxyprop-2-enamide::Cinnamic hydroxamate deriv., 10 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 61000 7.4 22.50 C Curated from the literature by BindingDB 10.1021/ol0603211 10.7270/Q247484W 16597152 aid1798310 Boldt, GE; Kennedy, JP; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23266 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23266&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 11715310 50091531 ZINC14980401 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42363 ONC(=O)\C=C\c1ccc(Br)cc1 InChI=1S/C9H8BrNO2/c10-8-4-1-7(2-5-8)3-6-9(12)11-13/h1-6,13H,(H,11,12)/b6-3+ DVRCLYFYRNXWEC-ZZXKWVIFSA-N 23267 (2E)-3-(4-bromophenyl)-N-hydroxyprop-2-enamide::Cinnamic hydroxamate deriv., 11 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 40000 7.4 22.50 C Curated from the literature by BindingDB 10.1021/ol0603211 10.7270/Q247484W 16597152 aid1798310 Boldt, GE; Kennedy, JP; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23267 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23267&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 11715696 50091532 ZINC14980404 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42364 ONC(=O)\C=C\c1ccc(F)cc1 InChI=1S/C9H8FNO2/c10-8-4-1-7(2-5-8)3-6-9(12)11-13/h1-6,13H,(H,11,12)/b6-3+ SCPSOYBREZOKTD-ZZXKWVIFSA-N 23268 (2E)-3-(4-fluorophenyl)-N-hydroxyprop-2-enamide::Cinnamic hydroxamate deriv., 12 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 54000 7.4 22.50 C Curated from the literature by BindingDB 10.1021/ol0603211 10.7270/Q247484W 16597152 aid1798310 Boldt, GE; Kennedy, JP; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23268&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 11687004 50091533 ZINC14980407 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42365 COc1ccc(\C=C\C(=O)NO)cc1 InChI=1S/C10H11NO3/c1-14-9-5-2-8(3-6-9)4-7-10(12)11-13/h2-7,13H,1H3,(H,11,12)/b7-4+ BQDLTSGIXOYYHY-QPJJXVBHSA-N 23269 (2E)-N-hydroxy-3-(4-methoxyphenyl)prop-2-enamide::Cinnamic hydroxamate deriv., 13::US10188756, Compound CN87::US11505523, Compound PCI34051 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 79000 7.4 22.50 C Curated from the literature by BindingDB 10.1021/ol0603211 10.7270/Q247484W 16597152 aid1798310 Boldt, GE; Kennedy, JP; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23269&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 6433883 50091534 ZINC05298904 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42366 CC(C)(C)c1ccc(\C=C\C(=O)NO)cc1 InChI=1S/C13H17NO2/c1-13(2,3)11-7-4-10(5-8-11)6-9-12(15)14-16/h4-9,16H,1-3H3,(H,14,15)/b9-6+ YAQWGLLWVLAPIR-RMKNXTFCSA-N 23270 (2E)-3-(4-tert-butylphenyl)-N-hydroxyprop-2-enamide::Cinnamic hydroxamate deriv., 14 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >100000 7.4 22.50 C Curated from the literature by BindingDB 10.1021/ol0603211 10.7270/Q247484W 16597152 aid1798310 Boldt, GE; Kennedy, JP; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23270 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23270&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 11564786 50091535 ZINC14980410 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42367 Cc1ccc(\C=C\C(=O)NO)cc1 InChI=1S/C10H11NO2/c1-8-2-4-9(5-3-8)6-7-10(12)11-13/h2-7,13H,1H3,(H,11,12)/b7-6+ DEQAPAAUGTUJDH-VOTSOKGWSA-N 23271 (2E)-N-hydroxy-3-(4-methylphenyl)prop-2-enamide::Cinnamic hydroxamate deriv., 15 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 87000 7.4 22.50 C Curated from the literature by BindingDB 10.1021/ol0603211 10.7270/Q247484W 16597152 aid1798310 Boldt, GE; Kennedy, JP; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23271 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23271&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 11542865 50091536 ZINC14980413 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42368 ONC(=O)\C=C\c1ccc(cc1)[N+]([O-])=O InChI=1S/C9H8N2O4/c12-9(10-13)6-3-7-1-4-8(5-2-7)11(14)15/h1-6,13H,(H,10,12)/b6-3+ DXSWHZGUZUBIMD-ZZXKWVIFSA-N 23272 (2E)-N-hydroxy-3-(4-nitrophenyl)prop-2-enamide::Cinnamic hydroxamate deriv., 16 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 72000 7.4 22.50 C Curated from the literature by BindingDB 10.1021/ol0603211 10.7270/Q247484W 16597152 aid1798310 Boldt, GE; Kennedy, JP; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23272 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23272&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 11658527 50091537 ZINC12583748 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42369 ONC(=O)\C=C\c1ccc(Cl)c(Cl)c1 InChI=1S/C9H7Cl2NO2/c10-7-3-1-6(5-8(7)11)2-4-9(13)12-14/h1-5,14H,(H,12,13)/b4-2+ AELVBNUQAWORKK-DUXPYHPUSA-N 23273 (2E)-3-(3,4-dichlorophenyl)-N-hydroxyprop-2-enamide::Cinnamic hydroxamate deriv., 17 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 75000 7.4 22.50 C Curated from the literature by BindingDB 10.1021/ol0603211 10.7270/Q247484W 16597152 aid1798310 Boldt, GE; Kennedy, JP; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23273 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23273&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 11572177 50091538 ZINC14980416 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42370 ONC(=O)\C=C\c1ccc(Cl)cc1Cl InChI=1S/C9H7Cl2NO2/c10-7-3-1-6(8(11)5-7)2-4-9(13)12-14/h1-5,14H,(H,12,13)/b4-2+ LHTLDFWBUPYUDR-DUXPYHPUSA-N 23274 (2E)-3-(2,4-dichlorophenyl)-N-hydroxyprop-2-enamide::BMC173072 Compound 2::BMCL176463 Compound 2::Cinnamic hydroxamate deriv., 18 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 410 7.4 22.50 C Curated from the literature by BindingDB 10.1021/ol0603211 10.7270/Q247484W 16597152 aid1798310 Boldt, GE; Kennedy, JP; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23274&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search GB4 2IMA 11708451 50091539 DB07818 ZINC14980419 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42371 ONC(=O)CCc1ccc(Cl)cc1Cl InChI=1S/C9H9Cl2NO2/c10-7-3-1-6(8(11)5-7)2-4-9(13)12-14/h1,3,5,14H,2,4H2,(H,12,13) GADQEASLKRYAPQ-UHFFFAOYSA-N 23275 3-(2,4-dichlorophenyl)-N-hydroxypropanamide::Cinnamic hydroxamate deriv., 19 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 3100 7.4 22.50 C Curated from the literature by BindingDB 10.1021/ol0603211 10.7270/Q247484W 16597152 aid1798310 Boldt, GE; Kennedy, JP; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23275 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23275&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 11637231 50091540 ZINC14980422 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42372 ONC(=O)C#Cc1ccc(Cl)cc1Cl InChI=1S/C9H5Cl2NO2/c10-7-3-1-6(8(11)5-7)2-4-9(13)12-14/h1,3,5,14H,(H,12,13) YPVHQWJMECBRGN-UHFFFAOYSA-N 23276 3-(2,4-dichlorophenyl)-N-hydroxyprop-2-ynamide::Cinnamic hydroxamate deriv., 20 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 73000 7.4 22.50 C Curated from the literature by BindingDB 10.1021/ol0603211 10.7270/Q247484W 16597152 aid1798310 Boldt, GE; Kennedy, JP; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23276&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 11564864 50091541 51723 ZINC14980425 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42373 ONC(=O)\C=C(/F)c1ccccc1 InChI=1S/C9H8FNO2/c10-8(6-9(12)11-13)7-4-2-1-3-5-7/h1-6,13H,(H,11,12)/b8-6- QKLOXCXNFIRJFY-VURMDHGXSA-N 23277 (2Z)-3-fluoro-N-hydroxy-3-phenylprop-2-enamide::Cinnamic hydroxamate deriv., 21 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >100000 7.4 22.50 C Curated from the literature by BindingDB 10.1021/ol0603211 10.7270/Q247484W 16597152 aid1798310 Boldt, GE; Kennedy, JP; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23277 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23277&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 11593538 50091542 ZINC14980427 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42374 ONC(=O)\C=C\c1ccc(Cl)cc1Cl InChI=1S/C9H7Cl2NO2/c10-7-3-1-6(8(11)5-7)2-4-9(13)12-14/h1-5,14H,(H,12,13)/b4-2+ LHTLDFWBUPYUDR-DUXPYHPUSA-N 23274 (2E)-3-(2,4-dichlorophenyl)-N-hydroxyprop-2-enamide::BMC173072 Compound 2::BMCL176463 Compound 2::Cinnamic hydroxamate deriv., 18 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 900 7.4 23.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.09.103 10.7270/Q20G3HFM 17951059 aid1798311 Capková, K; Yoneda, Y; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23274&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search GB4 2IMA 11708451 50091539 DB07818 ZINC14980419 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42375 ONC(=O)c1ccc2cc(Cl)ccc2c1 InChI=1S/C11H8ClNO2/c12-10-4-3-7-5-9(11(14)13-15)2-1-8(7)6-10/h1-6,15H,(H,13,14) JZBJTZUKTGJIEU-UHFFFAOYSA-N 23278 6-chloro-N-hydroxynaphthalene-2-carboxamide::hydroxamate derivative, 3a Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 21000 7.4 23.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.09.103 10.7270/Q20G3HFM 17951059 aid1798311 Capková, K; Yoneda, Y; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23278 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23278&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24860338 50091543 ZINC14980430 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42376 ONC(=O)c1ccc2cc(Br)ccc2c1 InChI=1S/C11H8BrNO2/c12-10-4-3-7-5-9(11(14)13-15)2-1-8(7)6-10/h1-6,15H,(H,13,14) ISVLPPSLEAIMLW-UHFFFAOYSA-N 23279 6-bromo-N-hydroxynaphthalene-2-carboxamide::hydroxamate derivative, 3b Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 71000 7.4 23.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.09.103 10.7270/Q20G3HFM 17951059 aid1798311 Capková, K; Yoneda, Y; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23279 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23279&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24860339 50091544 ZINC14980432 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42377 ONC(=O)C1=Cc2ccc(Cl)cc2C1 InChI=1S/C10H8ClNO2/c11-9-2-1-6-3-8(10(13)12-14)4-7(6)5-9/h1-3,5,14H,4H2,(H,12,13) AAOBGMNEDOOCPJ-UHFFFAOYSA-N 23280 6-chloro-N-hydroxy-1H-indene-2-carboxamide::hydroxamate derivative, 4a Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 41000 7.4 23.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.09.103 10.7270/Q20G3HFM 17951059 aid1798311 Capková, K; Yoneda, Y; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23280 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23280&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24860340 50091545 ZINC14980435 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42378 ONC(=O)c1cc2ccc(Cl)cc2s1 InChI=1S/C9H6ClNO2S/c10-6-2-1-5-3-8(9(12)11-13)14-7(5)4-6/h1-4,13H,(H,11,12) DJTXCACFMWXOPY-UHFFFAOYSA-N 23281 6-chloro-N-hydroxy-1-benzothiophene-2-carboxamide::hydroxamate derivative, 4b Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 45000 7.4 23.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.09.103 10.7270/Q20G3HFM 17951059 aid1798311 Capková, K; Yoneda, Y; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23281 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23281&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24860341 50091546 ZINC14980438 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42379 ONC(=O)c1cc2ccc(Cl)cc2[nH]1 InChI=1S/C9H7ClN2O2/c10-6-2-1-5-3-8(9(13)12-14)11-7(5)4-6/h1-4,11,14H,(H,12,13) MJZXECAJGGBTCY-UHFFFAOYSA-N 23282 6-chloro-N-hydroxy-1H-indole-2-carboxamide::hydroxamate derivative, 4c Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 7.4 23.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.09.103 10.7270/Q20G3HFM 17951059 aid1798311 Capková, K; Yoneda, Y; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23282 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23282&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24860342 50091547 ZINC14980441 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42380 Cn1c(cc2ccc(Cl)cc12)C(=O)NO InChI=1S/C10H9ClN2O2/c1-13-8-5-7(11)3-2-6(8)4-9(13)10(14)12-15/h2-5,15H,1H3,(H,12,14) JLSISWZOGFBFIG-UHFFFAOYSA-N 23283 6-chloro-N-hydroxy-1-methyl-1H-indole-2-carboxamide::hydroxamate derivative, 4d Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 38000 7.4 23.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.09.103 10.7270/Q20G3HFM 17951059 aid1798311 Capková, K; Yoneda, Y; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23283 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23283&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24860343 50091548 ZINC14980444 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42381 ONC(=O)\C=C\c1ccc(Cl)cc1F InChI=1S/C9H7ClFNO2/c10-7-3-1-6(8(11)5-7)2-4-9(13)12-14/h1-5,14H,(H,12,13)/b4-2+ KXZJNORZIFWCEQ-DUXPYHPUSA-N 23284 (2E)-3-(4-chloro-2-fluorophenyl)-N-hydroxyprop-2-enamide::hydroxamate derivative, 5a Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 4400 7.4 23.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.09.103 10.7270/Q20G3HFM 17951059 aid1798311 Capková, K; Yoneda, Y; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23284&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24860344 50091549 ZINC14980447 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42382 ONC(=O)\C=C\c1ccc(Cl)cc1Br InChI=1S/C9H7BrClNO2/c10-8-5-7(11)3-1-6(8)2-4-9(13)12-14/h1-5,14H,(H,12,13)/b4-2+ ZPZHUDNIWYGUEI-DUXPYHPUSA-N 23285 (2E)-3-(2-bromo-4-chlorophenyl)-N-hydroxyprop-2-enamide::hydroxamate derivative, 5b Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 700 7.4 23.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.09.103 10.7270/Q20G3HFM 17951059 aid1798311 Capková, K; Yoneda, Y; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23285 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23285&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24860345 50091550 ZINC14980450 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42383 COc1cc(Cl)ccc1\C=C\C(=O)NO InChI=1S/C10H10ClNO3/c1-15-9-6-8(11)4-2-7(9)3-5-10(13)12-14/h2-6,14H,1H3,(H,12,13)/b5-3+ GVEWAZKCDLNAGT-HWKANZROSA-N 23286 (2E)-3-(4-chloro-2-methoxyphenyl)-N-hydroxyprop-2-enamide::hydroxamate derivative, 5c Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 9000 7.4 23.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.09.103 10.7270/Q20G3HFM 17951059 aid1798311 Capková, K; Yoneda, Y; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23286 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23286&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24860346 50091551 ZINC14980453 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42384 CSc1cc(Cl)ccc1\C=C\C(=O)NO InChI=1S/C10H10ClNO2S/c1-15-9-6-8(11)4-2-7(9)3-5-10(13)12-14/h2-6,14H,1H3,(H,12,13)/b5-3+ QNJFXFXTGRXWGX-HWKANZROSA-N 23287 (2E)-3-[4-chloro-2-(methylsulfanyl)phenyl]-N-hydroxyprop-2-enamide::hydroxamate derivative, 5d Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 5100 7.4 23.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.09.103 10.7270/Q20G3HFM 17951059 aid1798311 Capková, K; Yoneda, Y; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23287 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23287&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24860347 50091552 ZINC14980456 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42385 Nc1cc(Cl)ccc1\C=C\C(=O)NO InChI=1S/C9H9ClN2O2/c10-7-3-1-6(8(11)5-7)2-4-9(13)12-14/h1-5,14H,11H2,(H,12,13)/b4-2+ CGUYZBKQJPCUDU-DUXPYHPUSA-N 23288 (2E)-3-(2-amino-4-chlorophenyl)-N-hydroxyprop-2-enamide::hydroxamate derivative, 5e Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 25000 7.4 23.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.09.103 10.7270/Q20G3HFM 17951059 aid1798311 Capková, K; Yoneda, Y; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23288 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23288&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24860348 50091553 ZINC14980459 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42386 Cc1cc(Cl)ccc1\C=C\C(=O)NO InChI=1S/C10H10ClNO2/c1-7-6-9(11)4-2-8(7)3-5-10(13)12-14/h2-6,14H,1H3,(H,12,13)/b5-3+ UWFUNUDRGMZSCC-HWKANZROSA-N 23289 (2E)-3-(4-chloro-2-methylphenyl)-N-hydroxyprop-2-enamide::hydroxamate derivative, 5f Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 800 7.4 23.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.09.103 10.7270/Q20G3HFM 17951059 aid1798311 Capková, K; Yoneda, Y; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23289 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23289&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24860349 50091554 ZINC14980462 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42387 ONC(=O)\C=C\c1ccc(Cl)cc1C(F)(F)F InChI=1S/C10H7ClF3NO2/c11-7-3-1-6(2-4-9(16)15-17)8(5-7)10(12,13)14/h1-5,17H,(H,15,16)/b4-2+ QPIVGZVHNQGGEK-DUXPYHPUSA-N 23290 (2E)-3-[4-chloro-2-(trifluoromethyl)phenyl]-N-hydroxyprop-2-enamide::hydroxamate derivative, 5g Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 600 7.4 23.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.09.103 10.7270/Q20G3HFM 17951059 aid1798311 Capková, K; Yoneda, Y; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23290 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23290&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24860350 50091555 ZINC14980465 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42388 ONC(=O)\C=C\c1ccc(Cl)cc1O InChI=1S/C9H8ClNO3/c10-7-3-1-6(8(12)5-7)2-4-9(13)11-14/h1-5,12,14H,(H,11,13)/b4-2+ KTEUXGWNTANXSO-DUXPYHPUSA-N 23291 (2E)-3-(4-chloro-2-hydroxyphenyl)-N-hydroxyprop-2-enamide::hydroxamate derivative, 5h Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 13000 7.4 23.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.09.103 10.7270/Q20G3HFM 17951059 aid1798311 Capková, K; Yoneda, Y; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23291 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23291&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24860351 50091556 ZINC14980468 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42389 ONC(=O)\C=C\c1ccc(Cl)cc1[N+]([O-])=O InChI=1S/C9H7ClN2O4/c10-7-3-1-6(2-4-9(13)11-14)8(5-7)12(15)16/h1-5,14H,(H,11,13)/b4-2+ SQLGBFXKOMALIA-DUXPYHPUSA-N 23292 (2E)-3-(4-chloro-2-nitrophenyl)-N-hydroxyprop-2-enamide::hydroxamate derivative, 5i Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 2000 7.4 23.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.09.103 10.7270/Q20G3HFM 17951059 aid1798311 Capková, K; Yoneda, Y; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23292&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24860352 50091557 ZINC14980471 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42390 CS(=O)(=O)c1cc(Cl)ccc1\C=C\C(=O)NO InChI=1S/C10H10ClNO4S/c1-17(15,16)9-6-8(11)4-2-7(9)3-5-10(13)12-14/h2-6,14H,1H3,(H,12,13)/b5-3+ ILXSBXNSALESLV-HWKANZROSA-N 23293 (2E)-3-(4-chloro-2-methanesulfonylphenyl)-N-hydroxyprop-2-enamide::hydroxamate derivative, 5j Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 17000 7.4 23.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.09.103 10.7270/Q20G3HFM 17951059 aid1798311 Capková, K; Yoneda, Y; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23293 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23293&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24860353 50091558 ZINC14980474 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42391 ONC(=O)\C=C\c1ccc(Cl)cc1C#N InChI=1S/C10H7ClN2O2/c11-9-3-1-7(8(5-9)6-12)2-4-10(14)13-15/h1-5,15H,(H,13,14)/b4-2+ BOOUJCSXTWQSDX-DUXPYHPUSA-N 23294 (2E)-3-(4-chloro-2-cyanophenyl)-N-hydroxyprop-2-enamide::hydroxamate derivative, 5k Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 12000 7.4 23.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.09.103 10.7270/Q20G3HFM 17951059 aid1798311 Capková, K; Yoneda, Y; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23294 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23294&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24860354 50091559 ZINC14980479 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42392 ONC(=O)\C=C\c1ccc(Cl)cc1 InChI=1S/C9H8ClNO2/c10-8-4-1-7(2-5-8)3-6-9(12)11-13/h1-6,13H,(H,11,12)/b6-3+ YPYUWBDOEMPXSK-ZZXKWVIFSA-N 23295 (2E)-3-(4-chlorophenyl)-N-hydroxyprop-2-enamide::4-chlorocinnamic hydroxamate, 1 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 15000 7.4 23.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.09.103 10.7270/Q20G3HFM 17951059 aid1798311 Capková, K; Yoneda, Y; Dickerson, TJ; Janda, KD The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23295 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23295&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search GB5 2ILP 11694089 50091560 DB07819 ZINC12583773 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42393 C[C@H](CCCNCCNc1ccnc2cc(Cl)ccc12)[C@H]1CCC2C3[C@@H](C[C@@H]4C[C@@H](CC[C@]4(C)C3C[C@H](OC(C)=O)[C@]12C)OC(C)=O)OC(C)=O InChI=1S/C41H58ClN3O6/c1-24(8-7-16-43-18-19-45-35-14-17-44-36-22-29(42)9-10-31(35)36)32-11-12-33-39-34(23-38(41(32,33)6)51-27(4)48)40(5)15-13-30(49-25(2)46)20-28(40)21-37(39)50-26(3)47/h9-10,14,17,22,24,28,30,32-34,37-39,43H,7-8,11-13,15-16,18-21,23H2,1-6H3,(H,44,45)/t24-,28+,30-,32-,33?,34?,37-,38+,39?,40+,41-/m1/s1 OIIVAUPRMHYHRI-GLYQTUQUSA-N 23296 (2S,5R,7S,9R,14R,15R,16S)-14-[(1R)-4-({2-[(7-chloroquinolin-4-yl)amino]ethyl}amino)-1-methylbutyl]-5,9-bis(acetyloxy)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-16-yl acetate::4-amino-7-chloroquinoline (ACQ)-based compound, 1::JMC514388 Compound 6 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 10000 7.3 22.00 C Curated from the literature by BindingDB 10.1021/jm061446e 10.7270/Q2VQ3105 17417831 aid1798312 Burnett, JC; Opsenica, D; Sriraghavan, K; Panchal, RG; Ruthel, G; Hermone, AR; Nguyen, TL; Kenny, TA; Lane, DJ; McGrath, CF; Schmidt, JJ; Vennerstrom, JL; Gussio, R; Solaja, BA; Bavari, S National Cancer Institute at Frederick http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23296 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23296&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 91896000 50091561 ZINC96308797 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42394 COC(=O)CC[C@@H](C)[C@H]1CCC2C3[C@@H](C[C@@H]4C[C@H](CC[C@]4(C)C3C[C@H](OC(C)=O)[C@]12C)NCCNc1ccnc2cc(Cl)ccc12)OC(C)=O InChI=1S/C40H56ClN3O6/c1-23(7-12-37(47)48-6)30-10-11-31-38-32(22-36(40(30,31)5)50-25(3)46)39(4)15-13-28(19-26(39)20-35(38)49-24(2)45)42-17-18-44-33-14-16-43-34-21-27(41)8-9-29(33)34/h8-9,14,16,21,23,26,28,30-32,35-36,38,42H,7,10-13,15,17-20,22H2,1-6H3,(H,43,44)/t23-,26+,28+,30-,31?,32?,35-,36+,38?,39+,40-/m1/s1 KRNXBGIVMRDNEB-AHBJFESSSA-N 23297 4-amino-7-chloroquinoline (ACQ)-based compound, 2::JMC514388 Compound 7::methyl (4R)-4-[(2S,5S,7S,9R,14R,15R,16S)-5-({2-[(7-chloroquinolin-4-yl)amino]ethyl}amino)-9,16-bis(acetyloxy)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoate Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 17000 7.3 22.00 C Curated from the literature by BindingDB 10.1021/jm061446e 10.7270/Q2VQ3105 17417831 aid1798312 Burnett, JC; Opsenica, D; Sriraghavan, K; Panchal, RG; Ruthel, G; Hermone, AR; Nguyen, TL; Kenny, TA; Lane, DJ; McGrath, CF; Schmidt, JJ; Vennerstrom, JL; Gussio, R; Solaja, BA; Bavari, S National Cancer Institute at Frederick http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23297 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23297&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 91896001 50091562 ZINC49942627 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42395 COC(=O)CC[C@@H](C)[C@H]1CCC2C3[C@@H](C[C@@H]4C[C@@H](CC[C@]4(C)C3C[C@H](OC(C)=O)[C@]12C)NCCNc1ccnc2cc(Cl)ccc12)OC(C)=O InChI=1S/C40H56ClN3O6/c1-23(7-12-37(47)48-6)30-10-11-31-38-32(22-36(40(30,31)5)50-25(3)46)39(4)15-13-28(19-26(39)20-35(38)49-24(2)45)42-17-18-44-33-14-16-43-34-21-27(41)8-9-29(33)34/h8-9,14,16,21,23,26,28,30-32,35-36,38,42H,7,10-13,15,17-20,22H2,1-6H3,(H,43,44)/t23-,26+,28-,30-,31?,32?,35-,36+,38?,39+,40-/m1/s1 KRNXBGIVMRDNEB-VIIPABMFSA-N 23298 4-amino-7-chloroquinoline (ACQ)-based compound, 3::JMC514388 Compound 8::methyl (4R)-4-[(2S,5R,7S,9R,14R,15R,16S)-5-({2-[(7-chloroquinolin-4-yl)amino]ethyl}amino)-9,16-bis(acetyloxy)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoate Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 7000 7.3 22.00 C Curated from the literature by BindingDB 10.1021/jm061446e 10.7270/Q2VQ3105 17417831 aid1798312 Burnett, JC; Opsenica, D; Sriraghavan, K; Panchal, RG; Ruthel, G; Hermone, AR; Nguyen, TL; Kenny, TA; Lane, DJ; McGrath, CF; Schmidt, JJ; Vennerstrom, JL; Gussio, R; Solaja, BA; Bavari, S National Cancer Institute at Frederick http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23298 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23298&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 91896002 50091563 ZINC49794050 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 42396 Clc1ccc2c(NCCCN(CCCNc3ccnc4cc(Cl)ccc34)CCCNc3ccnc4cc(Cl)ccc34)ccnc2c1 InChI=1S/C36H36Cl3N7/c37-25-4-7-28-31(10-16-43-34(28)22-25)40-13-1-19-46(20-2-14-41-32-11-17-44-35-23-26(38)5-8-29(32)35)21-3-15-42-33-12-18-45-36-24-27(39)6-9-30(33)36/h4-12,16-18,22-24H,1-3,13-15,19-21H2,(H,40,43)(H,41,44)(H,42,45) NEDFTNYEDKYQCR-UHFFFAOYSA-N 23299 4-amino-7-chloroquinoline (ACQ)-based compound, 4::N-{3-[bis({3-[(7-chloroquinolin-4-yl)amino]propyl})amino]propyl}-7-chloroquinolin-4-amine Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 3200 7.3 22.00 C Curated from the literature by BindingDB 10.1021/jm061446e 10.7270/Q2VQ3105 17417831 aid1798312 Burnett, JC; Opsenica, D; Sriraghavan, K; Panchal, RG; Ruthel, G; Hermone, AR; Nguyen, TL; Kenny, TA; Lane, DJ; McGrath, CF; Schmidt, JJ; Vennerstrom, JL; Gussio, R; Solaja, BA; Bavari, S National Cancer Institute at Frederick http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23299 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23299&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 16221560 50091564 ZINC28644739 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52486 OC(=O)CN1C(=S)S\C(=C/c2ccc(o2)-c2cccc(c2)[N+]([O-])=O)C1=O InChI=1S/C16H10N2O6S2/c19-14(20)8-17-15(21)13(26-16(17)25)7-11-4-5-12(24-11)9-2-1-3-10(6-9)18(22)23/h1-7H,8H2,(H,19,20)/b13-7- CEHNYMOHYRFEJA-QPEQYQDCSA-N 28844 2-[(5Z)-5-{[5-(3-nitrophenyl)furan-2-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 3 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28844 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28844&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 1611137 58098032 ZINC01835944 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52487 OC(=O)CN1C(=S)S\C(=C/c2ccc(o2)-c2ccc(cc2Cl)[N+]([O-])=O)C1=O InChI=1S/C16H9ClN2O6S2/c17-11-5-8(19(23)24)1-3-10(11)12-4-2-9(25-12)6-13-15(22)18(7-14(20)21)16(26)27-13/h1-6H,7H2,(H,20,21)/b13-6- CLHFOCNNCZBREZ-MLPAPPSSSA-N 28845 2-[(5Z)-5-{[5-(2-chloro-4-nitrophenyl)furan-2-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 4 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 11800 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28845 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28845&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 5923843 58098033 ZINC02700489 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52488 OC(=O)CC(N1C(=S)S\C(=C/c2ccc(o2)-c2ccc(Br)cc2)C1=O)C(O)=O InChI=1S/C18H12BrNO6S2/c19-10-3-1-9(2-4-10)13-6-5-11(26-13)7-14-16(23)20(18(27)28-14)12(17(24)25)8-15(21)22/h1-7,12H,8H2,(H,21,22)(H,24,25)/b14-7- KLTFJVAILHPIBO-AUWJEWJLSA-N 28846 2-[(5Z)-5-{[5-(4-bromophenyl)furan-2-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanedioic acid::rhodanine derivative, 5 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 51600 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28846 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28846&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 5941094 58098034 ZINC01802015 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52489 OC(=O)CCC(N1C(=S)S\C(=C/c2ccc(o2)-c2ccc(cc2)[N+]([O-])=O)C1=O)C(O)=O InChI=1S/C19H14N2O8S2/c22-16(23)8-6-13(18(25)26)20-17(24)15(31-19(20)30)9-12-5-7-14(29-12)10-1-3-11(4-2-10)21(27)28/h1-5,7,9,13H,6,8H2,(H,22,23)(H,25,26)/b15-9- AAYFBVCMIGADEC-DHDCSXOGSA-N 28847 2-[(5Z)-5-{[5-(4-nitrophenyl)furan-2-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]pentanedioic acid::rhodanine derivative, 6 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 148000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28847 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28847&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 5926535 58098035 ZINC02277663 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52490 OC(=O)C(N1C(=S)S\C(=C/c2ccc(o2)-c2cccc(c2)[N+]([O-])=O)C1=O)c1ccccc1 InChI=1S/C22H14N2O6S2/c25-20-18(32-22(31)23(20)19(21(26)27)13-5-2-1-3-6-13)12-16-9-10-17(30-16)14-7-4-8-15(11-14)24(28)29/h1-12,19H,(H,26,27)/b18-12- IVNZKITXBSOBQB-PDGQHHTCSA-N 28848 2-[(5Z)-5-{[5-(3-nitrophenyl)furan-2-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-2-phenylacetic acid::rhodanine derivative, 7 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28848 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28848&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 6511071 58098036 ZINC02700697 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52491 OC(=O)C(N1C(=S)S\C(=C/c2ccc(o2)-c2cccc(Cl)c2)C1=O)c1ccccc1 InChI=1S/C22H14ClNO4S2/c23-15-8-4-7-14(11-15)17-10-9-16(28-17)12-18-20(25)24(22(29)30-18)19(21(26)27)13-5-2-1-3-6-13/h1-12,19H,(H,26,27)/b18-12- LFBIGAVOWOLUCI-PDGQHHTCSA-N 28849 2-[(5Z)-5-{[5-(3-chlorophenyl)furan-2-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-2-phenylacetic acid::rhodanine derivative, 8 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 127000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28849 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28849&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 6518020 58098037 ZINC01805148 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52492 OS(=O)(=O)CCN1C(=S)S\C(=C/c2ccc(o2)-c2cccc(c2)[N+]([O-])=O)C1=O InChI=1S/C16H12N2O7S3/c19-15-14(27-16(26)17(15)6-7-28(22,23)24)9-12-4-5-13(25-12)10-2-1-3-11(8-10)18(20)21/h1-5,8-9H,6-7H2,(H,22,23,24)/b14-9- YLSWTGHHMBMISW-ZROIWOOFSA-N 28850 2-[(5Z)-5-{[5-(3-nitrophenyl)furan-2-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]ethane-1-sulfonic acid::rhodanine derivative, 9 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 9720 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28850 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28850&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 1565866 58098038 C15521 ZINC01774490 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52493 OS(=O)(=O)CCN1C(=S)S\C(=C/c2ccc(o2)-c2cccc(Cl)c2)C1=O InChI=1S/C16H12ClNO5S3/c17-11-3-1-2-10(8-11)13-5-4-12(23-13)9-14-15(19)18(16(24)25-14)6-7-26(20,21)22/h1-5,8-9H,6-7H2,(H,20,21,22)/b14-9- CUKZYGAOTUDVNI-ZROIWOOFSA-N 28851 2-[(5Z)-5-{[5-(3-chlorophenyl)furan-2-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]ethane-1-sulfonic acid::rhodanine derivative, 10 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 19900 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28851 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28851&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 2274131 58098039 C15521 ZINC02967488 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52494 OS(=O)(=O)CCN1C(=S)S\C(=C/c2ccc(o2)-c2ccc(Cl)c(Cl)c2)C1=O InChI=1S/C16H11Cl2NO5S3/c17-11-3-1-9(7-12(11)18)13-4-2-10(24-13)8-14-15(20)19(16(25)26-14)5-6-27(21,22)23/h1-4,7-8H,5-6H2,(H,21,22,23)/b14-8- NNDRZYGHDYCLBD-ZSOIEALJSA-N 28852 2-[(5Z)-5-{[5-(3,4-dichlorophenyl)furan-2-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]ethane-1-sulfonic acid::rhodanine derivative, 11 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 11100 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28852 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28852&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 1902509 58098040 C15521 ZINC02277826 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52495 OS(=O)(=O)CCN1C(=S)S\C(=C/c2ccc(o2)-c2ccc(Cl)cc2)C1=O InChI=1S/C16H12ClNO5S3/c17-11-3-1-10(2-4-11)13-6-5-12(23-13)9-14-15(19)18(16(24)25-14)7-8-26(20,21)22/h1-6,9H,7-8H2,(H,20,21,22)/b14-9- RMLGFCRZXIMZBO-ZROIWOOFSA-N 28853 2-[(5Z)-5-{[5-(4-chlorophenyl)furan-2-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]ethane-1-sulfonic acid::rhodanine derivative, 12 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28853 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28853&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 1903050 58098041 C15521 ZINC02278533 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52496 OC(=O)C(N1C(=S)S\C(=C/c2ccc(o2)-c2ccc(Cl)cc2Cl)C1=O)c1ccccc1 InChI=1S/C22H13Cl2NO4S2/c23-13-6-8-15(16(24)10-13)17-9-7-14(29-17)11-18-20(26)25(22(30)31-18)19(21(27)28)12-4-2-1-3-5-12/h1-11,19H,(H,27,28)/b18-11- SZVQQAZZAXAFCJ-WQRHYEAKSA-N 28854 2-[(5Z)-5-{[5-(2,4-dichlorophenyl)furan-2-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-2-phenylacetic acid::rhodanine derivative, 13 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28854 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28854&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 23474896 58098042 ZINC40567461 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52497 Clc1cccc(-c2ccc(\C=C3/SC(=S)N(C4CCS(=O)(=O)C4)C3=O)o2)c1Cl InChI=1S/C18H13Cl2NO4S3/c19-13-3-1-2-12(16(13)20)14-5-4-11(25-14)8-15-17(22)21(18(26)27-15)10-6-7-28(23,24)9-10/h1-5,8,10H,6-7,9H2/b15-8- PMUROIMDPOQTME-NVNXTCNLSA-N 28855 3-[(5Z)-5-{[5-(2,3-dichlorophenyl)furan-2-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]--thiolane-1,1-dione::rhodanine derivative, 14 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28855 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28855&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 2926347 58098043 ZINC13618520 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52498 Clc1ccc(-c2ccc(\C=C3/SC(=S)N(C4CCS(=O)(=O)C4)C3=O)o2)c(Cl)c1 InChI=1S/C18H13Cl2NO4S3/c19-10-1-3-13(14(20)7-10)15-4-2-12(25-15)8-16-17(22)21(18(26)27-16)11-5-6-28(23,24)9-11/h1-4,7-8,11H,5-6,9H2/b16-8- RWBSKTKSSIZQDB-PXNMLYILSA-N 28856 3-[(5Z)-5-{[5-(2,4-dichlorophenyl)furan-2-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]--thiolane-1,1-dione::rhodanine derivative, 15 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >100000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28856 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28856&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 5910920 58098044 ZINC16671260 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52499 Clc1ccc(Cl)c(c1)-c1ccc(\C=C2/SC(=S)N(CC3CCCO3)C2=O)o1 InChI=1S/C19H15Cl2NO3S2/c20-11-3-5-15(21)14(8-11)16-6-4-12(25-16)9-17-18(23)22(19(26)27-17)10-13-2-1-7-24-13/h3-6,8-9,13H,1-2,7,10H2/b17-9- NVNXJRIIIGQALF-MFOYZWKCSA-N 28857 (5Z)-5-{[5-(2,5-dichlorophenyl)furan-2-yl]methylidene}-3-(oxolan-2-ylmethyl)-2-sulfanylidene-1,3-thiazolidin-4-one::rhodanine derivative, 16 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >50000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28857 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28857&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 5790551 58098045 ZINC19893427 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52500 Cc1nc(\C=C2/SC(=S)N(CC(O)=O)C2=O)c(C)o1 InChI=1S/C11H10N2O4S2/c1-5-7(12-6(2)17-5)3-8-10(16)13(4-9(14)15)11(18)19-8/h3H,4H2,1-2H3,(H,14,15)/b8-3- SKPBYWKLYBPQTB-BAQGIRSFSA-N 28858 2-[(5Z)-5-[(2,5-dimethyl-1,3-oxazol-4-yl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 17 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28858 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28858&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24796769 58098046 ZINC62233318 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52501 CC(C)(C)OC(=O)N1CCC(CC1)c1nc(\C=C2/SC(=S)N(CC(O)=O)C2=O)cs1 InChI=1S/C19H23N3O5S3/c1-19(2,3)27-17(26)21-6-4-11(5-7-21)15-20-12(10-29-15)8-13-16(25)22(9-14(23)24)18(28)30-13/h8,10-11H,4-7,9H2,1-3H3,(H,23,24)/b13-8- SMNBGJDOUDSTBX-JYRVWZFOSA-N 28859 2-[(5Z)-5-[(2-{1-[(tert-butoxy)carbonyl]piperidin-4-yl}-1,3-thiazol-4-yl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 18 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 176000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28859 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28859&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24796770 58098047 ZINC62233320 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52502 Cc1nc(c(\C=C2/SC(=S)N(CC(O)=O)C2=O)s1)-c1ccccc1 InChI=1S/C16H12N2O3S3/c1-9-17-14(10-5-3-2-4-6-10)11(23-9)7-12-15(21)18(8-13(19)20)16(22)24-12/h2-7H,8H2,1H3,(H,19,20)/b12-7- KOASFMIVRVUAHJ-GHXNOFRVSA-N 28860 2-[(5Z)-5-[(2-methyl-4-phenyl-1,3-thiazol-5-yl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 19 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28860 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28860&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24796771 58098048 ZINC62233324 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52503 OC(=O)CN1C(=S)S\C(=C/c2cc(on2)-c2ccco2)C1=O InChI=1S/C13H8N2O5S2/c16-11(17)6-15-12(18)10(22-13(15)21)5-7-4-9(20-14-7)8-2-1-3-19-8/h1-5H,6H2,(H,16,17)/b10-5- YKABHXABHMCOGN-YHYXMXQVSA-N 28861 2-[(5Z)-5-{[5-(furan-2-yl)-1,2-oxazol-3-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 20 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28861 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28861&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24796772 58098049 ZINC62233328 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52504 OC(=O)CN1C(=S)S\C(=C/c2cc(on2)-c2ccccc2)C1=O InChI=1S/C15H10N2O4S2/c18-13(19)8-17-14(20)12(23-15(17)22)7-10-6-11(21-16-10)9-4-2-1-3-5-9/h1-7H,8H2,(H,18,19)/b12-7- VJTLPGXZPWOGFN-GHXNOFRVSA-N 28862 2-[(5Z)-4-oxo-5-[(5-phenyl-1,2-oxazol-3-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 21 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28862 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28862&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24796773 58098050 ZINC62233331 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52505 Cc1ccc(cc1)-c1cc(\C=C2/SC(=S)N(CC(O)=O)C2=O)no1 InChI=1S/C16H12N2O4S2/c1-9-2-4-10(5-3-9)12-6-11(17-22-12)7-13-15(21)18(8-14(19)20)16(23)24-13/h2-7H,8H2,1H3,(H,19,20)/b13-7- ALWDKRNKKUSDAD-QPEQYQDCSA-N 28863 2-[(5Z)-5-{[5-(4-methylphenyl)-1,2-oxazol-3-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 22 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 130000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28863 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28863&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24796891 58098051 ZINC62233335 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52506 COc1ccc(cc1)-c1cc(\C=C2/SC(=S)N(CC(O)=O)C2=O)no1 InChI=1S/C16H12N2O5S2/c1-22-11-4-2-9(3-5-11)12-6-10(17-23-12)7-13-15(21)18(8-14(19)20)16(24)25-13/h2-7H,8H2,1H3,(H,19,20)/b13-7- MOUUVXKKFWQCTC-QPEQYQDCSA-N 28864 2-[(5Z)-5-{[5-(4-methoxyphenyl)-1,2-oxazol-3-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 23 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 194000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28864 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28864&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24796892 58098052 ZINC62233339 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52507 OC(=O)CN1C(=S)S\C(=C/c2cc(on2)-c2ccc(Cl)cc2)C1=O InChI=1S/C15H9ClN2O4S2/c16-9-3-1-8(2-4-9)11-5-10(17-22-11)6-12-14(21)18(7-13(19)20)15(23)24-12/h1-6H,7H2,(H,19,20)/b12-6- ODDOQLCOHJDCCA-SDQBBNPISA-N 28865 2-[(5Z)-5-{[5-(4-chlorophenyl)-1,2-oxazol-3-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 24 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 82700 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28865 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28865&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24796893 58098053 ZINC62233342 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52508 OC(=O)CN1C(=S)S\C(=C/c2cc(on2)-c2ccc(F)cc2)C1=O InChI=1S/C15H9FN2O4S2/c16-9-3-1-8(2-4-9)11-5-10(17-22-11)6-12-14(21)18(7-13(19)20)15(23)24-12/h1-6H,7H2,(H,19,20)/b12-6- APGHNRXTUDIMJI-SDQBBNPISA-N 28866 2-[(5Z)-5-{[5-(4-fluorophenyl)-1,2-oxazol-3-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 25 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28866 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28866&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24796894 58098054 ZINC62233345 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52509 OC(=O)CN1C(=S)S\C(=C/c2cc(on2)-c2ccc(Br)cc2)C1=O InChI=1S/C15H9BrN2O4S2/c16-9-3-1-8(2-4-9)11-5-10(17-22-11)6-12-14(21)18(7-13(19)20)15(23)24-12/h1-6H,7H2,(H,19,20)/b12-6- CJXNHOVRLMZWDR-SDQBBNPISA-N 28867 2-[(5Z)-5-{[5-(4-bromophenyl)-1,2-oxazol-3-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 26 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28867 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28867&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24796895 58098055 ZINC62233349 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52510 OC(=O)CN1C(=S)SC(=Cc2c[nH]nc2-c2ccc(cc2)C(F)(F)F)C1=O InChI=1S/C16H10F3N3O3S2/c17-16(18,19)10-3-1-8(2-4-10)13-9(6-20-21-13)5-11-14(25)22(7-12(23)24)15(26)27-11/h1-6H,7H2,(H,20,21)(H,23,24) VNCOUSLJIZUUHN-UHFFFAOYSA-N 28868 2-[(5Z)-4-oxo-2-sulfanylidene-5-({3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl}methylidene)-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 27 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28868 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28868&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24796896 58098056 ZINC62233353 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52511 OC(=O)CN1C(=S)SC(=Cc2cc(n[nH]2)-c2ccc(Cl)cc2)C1=O InChI=1S/C15H10ClN3O3S2/c16-9-3-1-8(2-4-9)11-5-10(17-18-11)6-12-14(22)19(7-13(20)21)15(23)24-12/h1-6H,7H2,(H,17,18)(H,20,21) XSFCJSHSSJVHEZ-UHFFFAOYSA-N 28869 2-[(5Z)-5-{[5-(4-chlorophenyl)-1H-pyrazol-3-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 28 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28869 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28869&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24796897 58098057 ZINC62233357 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52512 OC(=O)CN1C(=S)S\C(=C/c2cn(nc2-c2cccs2)-c2ccccc2)C1=O InChI=1S/C19H13N3O3S3/c23-16(24)11-21-18(25)15(28-19(21)26)9-12-10-22(13-5-2-1-3-6-13)20-17(12)14-7-4-8-27-14/h1-10H,11H2,(H,23,24)/b15-9- IIILFUDXGNDMSG-DHDCSXOGSA-N 28870 2-[(5Z)-4-oxo-5-{[1-phenyl-3-(thiophen-2-yl)-1H-pyrazol-4-yl]methylidene}-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 29 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 160000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28870 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28870&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 5933485 58098058 ZINC02533632 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52513 OC(=O)CN1C(=S)S\C(=C/c2cn(nc2-c2ccccc2)-c2ccccc2)C1=O InChI=1S/C21H15N3O3S2/c25-18(26)13-23-20(27)17(29-21(23)28)11-15-12-24(16-9-5-2-6-10-16)22-19(15)14-7-3-1-4-8-14/h1-12H,13H2,(H,25,26)/b17-11- QFQDHIXYDLKLMU-BOPFTXTBSA-N 28871 2-[(5Z)-5-[(1,3-diphenyl-1H-pyrazol-4-yl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 30 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 111000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28871 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28871&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 5906152 58098059 ZINC02533179 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52514 OC(=O)CN1C(=S)S\C(=C/c2cn(nc2-c2ccc(cc2)S(=O)(=O)N2CCOCC2)-c2ccccc2)C1=O InChI=1S/C25H22N4O6S3/c30-22(31)16-28-24(32)21(37-25(28)36)14-18-15-29(19-4-2-1-3-5-19)26-23(18)17-6-8-20(9-7-17)38(33,34)27-10-12-35-13-11-27/h1-9,14-15H,10-13,16H2,(H,30,31)/b21-14- BCDLFRIOCGREND-STZFKDTASA-N 28872 2-[(5Z)-5-({3-[4-(morpholine-4-sulfonyl)phenyl]-1-phenyl-1H-pyrazol-4-yl}methylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 31 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28872 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28872&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 5933482 58098060 ZINC02533615 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52515 OC(=O)CN1C(=S)S\C(=C/c2cn(nc2-c2cccnc2)-c2ccc(F)cc2F)C1=O InChI=1S/C20H12F2N4O3S2/c21-13-3-4-15(14(22)7-13)26-9-12(18(24-26)11-2-1-5-23-8-11)6-16-19(29)25(10-17(27)28)20(30)31-16/h1-9H,10H2,(H,27,28)/b16-6- XODCELGRYWYGSN-SOFYXZRVSA-N 28873 2-[(5Z)-5-{[1-(2,4-difluorophenyl)-3-(pyridin-3-yl)-1H-pyrazol-4-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 32 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 71500 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28873 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28873&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24797012 58098061 ZINC62233365 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52546 OC(=O)CN1C(=S)S\C(=C/c2cn(nc2-c2ccc(F)cc2)-c2ccc(F)cc2)C1=O InChI=1S/C21H13F2N3O3S2/c22-14-3-1-12(2-4-14)19-13(10-26(24-19)16-7-5-15(23)6-8-16)9-17-20(29)25(11-18(27)28)21(30)31-17/h1-10H,11H2,(H,27,28)/b17-9- HKHJWHYNEFUCJV-MFOYZWKCSA-N 28874 2-[(5Z)-5-{[1,3-bis(4-fluorophenyl)-1H-pyrazol-4-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 33 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 52600 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28874 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28874&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24797013 58098062 ZINC62233371 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52547 OC(=O)CN1C(=S)S\C(=C/c2cn(nc2-c2ccc(Cl)cc2)-c2ccc(Cl)cc2)C1=O InChI=1S/C21H13Cl2N3O3S2/c22-14-3-1-12(2-4-14)19-13(10-26(24-19)16-7-5-15(23)6-8-16)9-17-20(29)25(11-18(27)28)21(30)31-17/h1-10H,11H2,(H,27,28)/b17-9- RUOWADXYMCPHBQ-MFOYZWKCSA-N 28875 2-[(5Z)-5-{[1,3-bis(4-chlorophenyl)-1H-pyrazol-4-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 34 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 8180 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28875 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28875&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24797014 58098063 ZINC62233374 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52548 OC(=O)CN1C(=S)S\C(=C/c2cn(nc2-c2ccc(Br)cc2)-c2ccc(Br)cc2)C1=O InChI=1S/C21H13Br2N3O3S2/c22-14-3-1-12(2-4-14)19-13(10-26(24-19)16-7-5-15(23)6-8-16)9-17-20(29)25(11-18(27)28)21(30)31-17/h1-10H,11H2,(H,27,28)/b17-9- SKMKYPSCOBUCDE-MFOYZWKCSA-N 28876 2-[(5Z)-5-{[1,3-bis(4-bromophenyl)-1H-pyrazol-4-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 35 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 5450 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28876 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28876&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24797015 58098064 ZINC70622136 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52549 COc1ccc(cc1C)-c1nn(cc1\C=C1/SC(=S)N(CC(O)=O)C1=O)-c1ccccc1 InChI=1S/C23H19N3O4S2/c1-14-10-15(8-9-18(14)30-2)21-16(12-26(24-21)17-6-4-3-5-7-17)11-19-22(29)25(13-20(27)28)23(31)32-19/h3-12H,13H2,1-2H3,(H,27,28)/b19-11- AYLSYZOUBCZVJI-ODLFYWEKSA-N 28877 2-[(5Z)-5-{[3-(4-methoxy-3-methylphenyl)-1-phenyl-1H-pyrazol-4-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 36 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 127000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28877 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28877&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 1546011 58098065 ZINC01480061 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52550 CCOc1ccc(-c2nn(cc2\C=C2/SC(=S)N(CC(O)=O)C2=O)-c2ccccc2)c(C)c1 InChI=1S/C24H21N3O4S2/c1-3-31-18-9-10-19(15(2)11-18)22-16(13-27(25-22)17-7-5-4-6-8-17)12-20-23(30)26(14-21(28)29)24(32)33-20/h4-13H,3,14H2,1-2H3,(H,28,29)/b20-12- RNHOYMKTWGKXSJ-NDENLUEZSA-N 28878 2-[(5Z)-5-{[3-(4-ethoxy-2-methylphenyl)-1-phenyl-1H-pyrazol-4-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 37 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 130000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28878 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28878&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 1981409 58098066 ZINC02370886 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52551 OS(=O)(=O)CCN1C(=S)S\C(=C/c2cn(nc2-c2ccc(OCc3ccc(Cl)cc3)cc2)-c2ccccc2)C1=O InChI=1S/C28H22ClN3O5S3/c29-22-10-6-19(7-11-22)18-37-24-12-8-20(9-13-24)26-21(17-32(30-26)23-4-2-1-3-5-23)16-25-27(33)31(28(38)39-25)14-15-40(34,35)36/h1-13,16-17H,14-15,18H2,(H,34,35,36)/b25-16- UEMVHDDFBLKUGI-XYGWBWBKSA-N 28879 2-[(5Z)-5-[(3-{4-[(4-chlorophenyl)methoxy]phenyl}-1-phenyl-1H-pyrazol-4-yl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]ethane-1-sulfonic acid::cid_4601225::rhodanine derivative, 38 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28879 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28879&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 6161281 58098067 C15521 ZINC49670134 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52552 CC1Cc2cc(ccc2O1)-c1nn(cc1\C=C1/SC(=S)N(CCS(O)(=O)=O)C1=O)-c1ccccc1 InChI=1S/C24H21N3O5S3/c1-15-11-17-12-16(7-8-20(17)32-15)22-18(14-27(25-22)19-5-3-2-4-6-19)13-21-23(28)26(24(33)34-21)9-10-35(29,30)31/h2-8,12-15H,9-11H2,1H3,(H,29,30,31)/b21-13- PCLJWEZUOYANNR-BKUYFWCQSA-N 28880 2-[(5Z)-5-{[3-(2-methyl-2,3-dihydro-1-benzofuran-5-yl)-1-phenyl-1H-pyrazol-4-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]ethane-1-sulfonic acid::rhodanine derivative, 39 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28880 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28880&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 5933483 58098068 C15521 ZINC70622137 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52553 COc1ccc(cc1)-c1nn(cc1\C=C1/SC(=S)N(CCS(O)(=O)=O)C1=O)-c1ccccc1 InChI=1S/C22H19N3O5S3/c1-30-18-9-7-15(8-10-18)20-16(14-25(23-20)17-5-3-2-4-6-17)13-19-21(26)24(22(31)32-19)11-12-33(27,28)29/h2-10,13-14H,11-12H2,1H3,(H,27,28,29)/b19-13- WHBGBEVNCRHNNL-UYRXBGFRSA-N 28881 2-[(5Z)-5-{[3-(4-methoxyphenyl)-1-phenyl-1H-pyrazol-4-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]ethane-1-sulfonic acid::rhodanine derivative, 40 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28881 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28881&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 6297117 58098069 C15521 ZINC12274914 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52554 OS(=O)(=O)CCN1C(=S)S\C(=C/c2cn(nc2-c2ccc(Cl)cc2)-c2ccccc2)C1=O InChI=1S/C21H16ClN3O4S3/c22-16-8-6-14(7-9-16)19-15(13-25(23-19)17-4-2-1-3-5-17)12-18-20(26)24(21(30)31-18)10-11-32(27,28)29/h1-9,12-13H,10-11H2,(H,27,28,29)/b18-12- VFKFCXZLDLEWAH-PDGQHHTCSA-N 28882 2-[(5Z)-5-{[3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]ethane-1-sulfonic acid::rhodanine derivative, 41 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 26400 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28882&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 5857663 58098070 C15521 ZINC26967571 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52555 OS(=O)(=O)CCN1C(=S)S\C(=C/c2cn(nc2-c2ccc(cc2)S(=O)(=O)N2CCOCC2)-c2ccccc2)C1=O InChI=1S/C25H24N4O7S4/c30-24-22(38-25(37)28(24)12-15-39(31,32)33)16-19-17-29(20-4-2-1-3-5-20)26-23(19)18-6-8-21(9-7-18)40(34,35)27-10-13-36-14-11-27/h1-9,16-17H,10-15H2,(H,31,32,33)/b22-16- ZDENYKJDBBSGDF-JWGURIENSA-N 28883 2-[(5Z)-5-({3-[4-(morpholine-4-sulfonyl)phenyl]-1-phenyl-1H-pyrazol-4-yl}methylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]ethane-1-sulfonic acid::rhodanine derivative, 42 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 85000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28883 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28883&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 6263372 58098071 C15521 ZINC49745270 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52556 OS(=O)(=O)CCN1C(=S)S\C(=C/c2cn(nc2-c2ccc(cc2)S(=O)(=O)N2CCCCC2)-c2ccccc2)C1=O InChI=1S/C26H26N4O6S4/c31-25-23(38-26(37)29(25)15-16-39(32,33)34)17-20-18-30(21-7-3-1-4-8-21)27-24(20)19-9-11-22(12-10-19)40(35,36)28-13-5-2-6-14-28/h1,3-4,7-12,17-18H,2,5-6,13-16H2,(H,32,33,34)/b23-17- CULPOYNTOOOYIX-QJOMJCCJSA-N 28884 2-[(5Z)-4-oxo-5-({1-phenyl-3-[4-(piperidine-1-sulfonyl)phenyl]-1H-pyrazol-4-yl}methylidene)-2-sulfanylidene-1,3-thiazolidin-3-yl]ethane-1-sulfonic acid::rhodanine derivative, 43 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 20100 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28884 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28884&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 6166563 58098072 C15521 ZINC49670025 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52557 O=C1N(C2CCS(=O)(=O)C2)C(=S)S\C1=C/c1cn(nc1-c1ccccc1)-c1ccccc1 InChI=1S/C23H19N3O3S3/c27-22-20(31-23(30)26(22)19-11-12-32(28,29)15-19)13-17-14-25(18-9-5-2-6-10-18)24-21(17)16-7-3-1-4-8-16/h1-10,13-14,19H,11-12,15H2/b20-13- KRXPYMYTXNKEIY-MOSHPQCFSA-N 28885 3-[(5Z)-5-[(1,3-diphenyl-1H-pyrazol-4-yl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]--thiolane-1,1-dione::rhodanine derivative, 44 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28885 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28885&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 5727132 58098073 ZINC02283889 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52558 Clc1ccc(cc1)-c1nn(cc1\C=C1/SC(=S)N(C2CCS(=O)(=O)C2)C1=O)-c1ccccc1 InChI=1S/C23H18ClN3O3S3/c24-17-8-6-15(7-9-17)21-16(13-26(25-21)18-4-2-1-3-5-18)12-20-22(28)27(23(31)32-20)19-10-11-33(29,30)14-19/h1-9,12-13,19H,10-11,14H2/b20-12- AMPOUGCJFWSGHJ-NDENLUEZSA-N 28886 3-[(5Z)-5-{[3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]--thiolane-1,1-dione::rhodanine derivative, 45 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28886 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28886&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 5727255 58098074 ZINC13739178 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52559 CCOc1ccc(cc1F)-c1nn(cc1\C=C1/SC(=S)N(CC(O)=O)C1=O)-c1ccccc1 InChI=1S/C23H18FN3O4S2/c1-2-31-18-9-8-14(10-17(18)24)21-15(12-27(25-21)16-6-4-3-5-7-16)11-19-22(30)26(13-20(28)29)23(32)33-19/h3-12H,2,13H2,1H3,(H,28,29)/b19-11- XLTVGWJFFRORGR-ODLFYWEKSA-N 28887 2-[(5Z)-5-{[3-(4-ethoxy-3-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 46 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28887 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28887&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 1306416 58098075 ZINC16266013 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52560 OC(=O)CN1C(=S)S\C(=C/c2sc(Br)c3OCCOc23)C1=O InChI=1S/C12H8BrNO5S3/c13-10-9-8(18-1-2-19-9)5(21-10)3-6-11(17)14(4-7(15)16)12(20)22-6/h3H,1-2,4H2,(H,15,16)/b6-3- WOGKVMKDWRZQCE-UTCJRWHESA-N 28888 2-[(5Z)-5-({7-bromo-2H,3H-thieno[3,4-b][1,4]dioxin-5-yl}methylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 47 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28888 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28888&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24797016 58098076 ZINC62233378 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52561 OC(=O)CN1C(=S)S\C(=C/c2ccc(s2)N2CCOCC2)C1=O InChI=1S/C14H14N2O4S3/c17-12(18)8-16-13(19)10(23-14(16)21)7-9-1-2-11(22-9)15-3-5-20-6-4-15/h1-2,7H,3-6,8H2,(H,17,18)/b10-7- JLFSPLWIPOIDGX-YFHOEESVSA-N 28889 2-[(5Z)-5-{[5-(morpholin-4-yl)thiophen-2-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 48 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 112000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28889 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28889&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24797017 58098077 ZINC62233381 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52562 OC(=O)CN1C(=S)S\C(=C/c2ccc(cc2)-c2ccccc2)C1=O InChI=1S/C18H13NO3S2/c20-16(21)11-19-17(22)15(24-18(19)23)10-12-6-8-14(9-7-12)13-4-2-1-3-5-13/h1-10H,11H2,(H,20,21)/b15-10- MZRQRBAXYNSSEV-GDNBJRDFSA-N 28890 2-[(5Z)-4-oxo-5-[(4-phenylphenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 49 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 54600 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28890 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28890&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 2648225 58098078 ZINC03532608 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52563 OC(=O)CN1C(=S)S\C(=C/c2cccc(c2)N2CCCC2)C1=O InChI=1S/C16H16N2O3S2/c19-14(20)10-18-15(21)13(23-16(18)22)9-11-4-3-5-12(8-11)17-6-1-2-7-17/h3-5,8-9H,1-2,6-7,10H2,(H,19,20)/b13-9- JSGUDOLDZSZXPC-LCYFTJDESA-N 28891 2-[(5Z)-4-oxo-5-{[3-(pyrrolidin-1-yl)phenyl]methylidene}-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 50 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28891 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28891&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24797143 58098079 ZINC62233386 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52564 CN1CCCN(CC1)c1ccc(\C=C2/SC(=S)N(CC(O)=O)C2=O)cc1 InChI=1S/C18H21N3O3S2/c1-19-7-2-8-20(10-9-19)14-5-3-13(4-6-14)11-15-17(24)21(12-16(22)23)18(25)26-15/h3-6,11H,2,7-10,12H2,1H3,(H,22,23)/b15-11- POHKKTNIKJPBBF-PTNGSMBKSA-N 28892 2-[(5Z)-5-{[4-(4-methyl-1,4-diazepan-1-yl)phenyl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 51 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >50000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28892 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28892&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24797144 58098080 ZINC62233388 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52565 OC(=O)CN1C(=S)S\C(=C/c2cccc(c2)-n2cccn2)C1=O InChI=1S/C15H11N3O3S2/c19-13(20)9-17-14(21)12(23-15(17)22)8-10-3-1-4-11(7-10)18-6-2-5-16-18/h1-8H,9H2,(H,19,20)/b12-8- WAOTXPMDADWYKJ-WQLSENKSSA-N 28893 2-[(5Z)-4-oxo-5-{[3-(1H-pyrazol-1-yl)phenyl]methylidene}-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 52 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28893 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28893&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24797145 58098081 ZINC62233392 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52566 OC(=O)CN1C(=S)S\C(=C/c2ccc3OCOc3c2)C1=O InChI=1S/C13H9NO5S2/c15-11(16)5-14-12(17)10(21-13(14)20)4-7-1-2-8-9(3-7)19-6-18-8/h1-4H,5-6H2,(H,15,16)/b10-4- LJHBZLNAIVJDIT-WMZJFQQLSA-N 28894 2-[(5Z)-5-(2H-1,3-benzodioxol-5-ylmethylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 53 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28894 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28894&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 1201188 58098082 ZINC00966925 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52567 Cc1ccc2cc(\C=C3/SC(=S)N(CC(O)=O)C3=O)ccc2n1 InChI=1S/C16H12N2O3S2/c1-9-2-4-11-6-10(3-5-12(11)17-9)7-13-15(21)18(8-14(19)20)16(22)23-13/h2-7H,8H2,1H3,(H,19,20)/b13-7- BUXJDQVINJKXFZ-QPEQYQDCSA-N 28895 2-[(5Z)-5-[(2-methylquinolin-6-yl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 54 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28895 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28895&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24797146 58098083 ZINC62233397 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52568 OC(=O)CN1C(=S)S\C(=C/c2cccc3c4ccccc4oc23)C1=O InChI=1S/C18H11NO4S2/c20-15(21)9-19-17(22)14(25-18(19)24)8-10-4-3-6-12-11-5-1-2-7-13(11)23-16(10)12/h1-8H,9H2,(H,20,21)/b14-8- OGSMONDZJYBMGH-ZSOIEALJSA-N 28896 2-[(5Z)-5-{8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),2,4,6,10,12-hexaen-6-ylmethylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 55 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 160000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28896 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28896&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24797147 58098084 ZINC62233403 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52569 OC(=O)CN1C(=S)S\C(=C/c2cccc(Br)n2)C1=O InChI=1S/C11H7BrN2O3S2/c12-8-3-1-2-6(13-8)4-7-10(17)14(5-9(15)16)11(18)19-7/h1-4H,5H2,(H,15,16)/b7-4- MJQDGMLVGVHULA-DAXSKMNVSA-N 28897 2-[(5Z)-5-[(6-bromopyridin-2-yl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 56 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28897 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28897&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24797148 58098085 ZINC62233408 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52570 OC(=O)CN1C(=S)S\C(=C/c2csc3ccccc23)C1=O InChI=1S/C14H9NO3S3/c16-12(17)6-15-13(18)11(21-14(15)19)5-8-7-20-10-4-2-1-3-9(8)10/h1-5,7H,6H2,(H,16,17)/b11-5- OUWYJOICAYBELE-WZUFQYTHSA-N 28898 2-[(5Z)-5-(1-benzothiophen-3-ylmethylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 57 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28898 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28898&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 20042578 58098086 ZINC62233412 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52571 OC(=O)CN1C(=S)S\C(=C/c2csc3ccc(Br)cc23)C1=O InChI=1S/C14H8BrNO3S3/c15-8-1-2-10-9(4-8)7(6-21-10)3-11-13(19)16(5-12(17)18)14(20)22-11/h1-4,6H,5H2,(H,17,18)/b11-3- FTGDEGHLFLATCJ-JYOAFUTRSA-N 28899 2-[(5Z)-5-[(5-bromo-1-benzothiophen-3-yl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 58 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 74300 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28899&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24795159 58098087 ZINC62233416 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52572 OC(=O)CN1C(=S)S\C(=C/c2cc3nccnc3s2)C1=O InChI=1S/C12H7N3O3S3/c16-9(17)5-15-11(18)8(21-12(15)19)4-6-3-7-10(20-6)14-2-1-13-7/h1-4H,5H2,(H,16,17)/b8-4- RCNQALRGCKVWES-YWEYNIOJSA-N 28900 2-[(5Z)-4-oxo-2-sulfanylidene-5-{thieno[2,3-b]pyrazin-6-ylmethylidene}-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 59 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28900 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28900&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 24795160 58098088 ZINC62233419 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52573 OC(=O)CN1C(=S)S\C(=C/c2c[nH]c3ccccc23)C1=O InChI=1S/C14H10N2O3S2/c17-12(18)7-16-13(19)11(21-14(16)20)5-8-6-15-10-4-2-1-3-9(8)10/h1-6,15H,7H2,(H,17,18)/b11-5- PFEOKQKYEJFZNV-WZUFQYTHSA-N 28901 2-[(5Z)-5-(1H-indol-3-ylmethylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 60 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28901 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28901&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 5340039 58098089 ZINC01322431 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52574 OC(=O)CN1C(=S)S\C(=C/c2c[nH]c3ccc(Br)cc23)C1=O InChI=1S/C14H9BrN2O3S2/c15-8-1-2-10-9(4-8)7(5-16-10)3-11-13(20)17(6-12(18)19)14(21)22-11/h1-5,16H,6H2,(H,18,19)/b11-3- HYOWOVPPXHUVJI-JYOAFUTRSA-N 28902 2-[(5Z)-5-[(5-bromo-1H-indol-3-yl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid::rhodanine derivative, 61 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28902 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28902&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 5963118 58098090 ZINC01639619 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52575 OC(=O)CN1C(=S)S\C(C1=O)=C1/C(=O)N(CC(=O)Nc2cccc(Cl)c2)c2ccccc12 InChI=1S/C21H14ClN3O5S2/c22-11-4-3-5-12(8-11)23-15(26)9-24-14-7-2-1-6-13(14)17(19(24)29)18-20(30)25(10-16(27)28)21(31)32-18/h1-8H,9-10H2,(H,23,26)(H,27,28)/b18-17- WYRWIZUSWGLKCX-ZCXUNETKSA-N 28903 2-{5-[(3Z)-1-{[(3-chlorophenyl)carbamoyl]methyl}-2-oxo-2,3-dihydro-1H-indol-3-ylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl}acetic acid::rhodanine derivative, 62 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798937 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28903 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28903&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 5912285 58098091 ZINC03640302 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52611 Cc1cccc(NC(=O)CN2C(=O)\C(=C3/SC(=S)N(CC(O)=O)C3=O)c3ccccc23)c1 InChI=1S/C22H17N3O5S2/c1-12-5-4-6-13(9-12)23-16(26)10-24-15-8-3-2-7-14(15)18(20(24)29)19-21(30)25(11-17(27)28)22(31)32-19/h2-9H,10-11H2,1H3,(H,23,26)(H,27,28)/b19-18- XKCXKEBZTDNOFH-HNENSFHCSA-N 28904 2-{5-[(3Z)-1-{[(3-methylphenyl)carbamoyl]methyl}-2-oxo-2,3-dihydro-1H-indol-3-ylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl}acetic acid::rhodanine derivative, 63 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum >200000 Curated from the literature by BindingDB 10.1111/j.1747-0285.2007.00617.x 10.7270/Q2KW5DCN 18221310 aid1798938 Johnson, SL; Chen, LH; Harbach, R; Sabet, M; Savinov, A; Cotton, NJ; Strongin, A; Guiney, D; Pellecchia, M Burnham Institute for Medical Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28904 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28904&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 5942185 58098092 ZINC15227189 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52636 SCCC(=O)Nc1cc(n[nH]1)-c1ccc(Cl)cc1 InChI=1S/C12H12ClN3OS/c13-9-3-1-8(2-4-9)10-7-11(16-15-10)14-12(17)5-6-18/h1-4,7,18H,5-6H2,(H2,14,15,16,17) CPIWTJLPEQOGKG-UHFFFAOYSA-N 28905 3-mercaptopropionamide analog, 5::N-[3-(4-chlorophenyl)-1H-pyrazol-5-yl]-3-sulfanylpropanamide Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 195000 7.4 22.00 C Curated from the literature by BindingDB 10.1016/j.bmc.2009.03.013 10.7270/Q2G44NMS 19329331 aid1798945 Moe, ST; Thompson, AB; Smith, GM; Fredenburg, RA; Stein, RL; Jacobson, AR Absolute Science, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28905 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28905&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 25263435 58098093 ZINC40940557 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52637 SCC(=O)Nc1cc(n[nH]1)-c1ccc(Cl)cc1 InChI=1S/C11H10ClN3OS/c12-8-3-1-7(2-4-8)9-5-10(15-14-9)13-11(16)6-17/h1-5,17H,6H2,(H2,13,14,15,16) JALQHWDJULITDF-UHFFFAOYSA-N 28906 2-mercaptoacetamide, 12a::N-[3-(4-chlorophenyl)-1H-pyrazol-5-yl]-2-sulfanylacetamide Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 4800 7.4 22.00 C Curated from the literature by BindingDB 10.1016/j.bmc.2009.03.013 10.7270/Q2G44NMS 19329331 aid1798945 Moe, ST; Thompson, AB; Smith, GM; Fredenburg, RA; Stein, RL; Jacobson, AR Absolute Science, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28906 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28906&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 90G 5V8P 25260346 58098094 ZINC40943187 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52638 OCC(=O)Nc1cc(n[nH]1)-c1ccc(Cl)cc1 InChI=1S/C11H10ClN3O2/c12-8-3-1-7(2-4-8)9-5-10(15-14-9)13-11(17)6-16/h1-5,16H,6H2,(H2,13,14,15,17) AETCAFMFNRCJNE-UHFFFAOYSA-N 28907 2-hydroxyacetamide, 6::N-[3-(4-chlorophenyl)-1H-pyrazol-5-yl]-2-hydroxyacetamide Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 7.4 22.00 C Curated from the literature by BindingDB 10.1016/j.bmc.2009.03.013 10.7270/Q2G44NMS 19329331 aid1798945 Moe, ST; Thompson, AB; Smith, GM; Fredenburg, RA; Stein, RL; Jacobson, AR Absolute Science, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28907 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28907&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 25263436 58098095 ZINC40413202 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52639 CC(=O)Nc1cc(n[nH]1)-c1ccc(Cl)cc1 InChI=1S/C11H10ClN3O/c1-7(16)13-11-6-10(14-15-11)8-2-4-9(12)5-3-8/h2-6H,1H3,(H2,13,14,15,16) IIKSZRFVYVTNHL-UHFFFAOYSA-N 28908 N-[3-(4-chlorophenyl)-1H-pyrazol-5-yl]acetamide::N-[5-(4-chlorophenyl)-1H-pyrazol-3-yl]acetamide::acetamide, 7 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 7.4 22.00 C Curated from the literature by BindingDB 10.1016/j.bmc.2009.03.013 10.7270/Q2G44NMS 19329331 aid1798945 Moe, ST; Thompson, AB; Smith, GM; Fredenburg, RA; Stein, RL; Jacobson, AR Absolute Science, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28908 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28908&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 794164 58098096 ZINC06493448 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52640 SCC(=O)Nc1cc(n[nH]1)-c1ccccc1 InChI=1S/C11H11N3OS/c15-11(7-16)12-10-6-9(13-14-10)8-4-2-1-3-5-8/h1-6,16H,7H2,(H2,12,13,14,15) RNYVHBNOOYTLKH-UHFFFAOYSA-N 28909 2-mercaptoacetamide, 12e::N-(3-phenyl-1H-pyrazol-5-yl)-2-sulfanylacetamide Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 14500 7.4 22.00 C Curated from the literature by BindingDB 10.1016/j.bmc.2009.03.013 10.7270/Q2G44NMS 19329331 aid1798945 Moe, ST; Thompson, AB; Smith, GM; Fredenburg, RA; Stein, RL; Jacobson, AR Absolute Science, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28909 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28909&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 25258061 58098097 ZINC40937171 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52641 Fc1ccc(cc1)-c1cc(NC(=O)CS)[nH]n1 InChI=1S/C11H10FN3OS/c12-8-3-1-7(2-4-8)9-5-10(15-14-9)13-11(16)6-17/h1-5,17H,6H2,(H2,13,14,15,16) PXBCCXFDIBDLDW-UHFFFAOYSA-N 28910 2-mercaptoacetamide, 12h::N-[3-(4-fluorophenyl)-1H-pyrazol-5-yl]-2-sulfanylacetamide Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 13500 7.4 22.00 C Curated from the literature by BindingDB 10.1016/j.bmc.2009.03.013 10.7270/Q2G44NMS 19329331 aid1798945 Moe, ST; Thompson, AB; Smith, GM; Fredenburg, RA; Stein, RL; Jacobson, AR Absolute Science, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28910 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28910&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 25258515 58098098 ZINC40835597 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52642 SCC(=O)Nc1cc(n[nH]1)-c1ccc(Br)cc1 InChI=1S/C11H10BrN3OS/c12-8-3-1-7(2-4-8)9-5-10(15-14-9)13-11(16)6-17/h1-5,17H,6H2,(H2,13,14,15,16) PXVVPBAZRAXZKB-UHFFFAOYSA-N 28911 2-mercaptoacetamide, 12i::N-[3-(4-bromophenyl)-1H-pyrazol-5-yl]-2-sulfanylacetamide Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 6600 7.4 22.00 C Curated from the literature by BindingDB 10.1016/j.bmc.2009.03.013 10.7270/Q2G44NMS 19329331 aid1798945 Moe, ST; Thompson, AB; Smith, GM; Fredenburg, RA; Stein, RL; Jacobson, AR Absolute Science, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28911 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28911&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 25258281 58098099 ZINC40836027 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52643 FC(F)(F)c1ccc(cc1)-c1cc(NC(=O)CS)[nH]n1 InChI=1S/C12H10F3N3OS/c13-12(14,15)8-3-1-7(2-4-8)9-5-10(18-17-9)16-11(19)6-20/h1-5,20H,6H2,(H2,16,17,18,19) IGUGCSGKQNBGEF-UHFFFAOYSA-N 28912 2-mercaptoacetamide, 12d::2-sulfanyl-N-{3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-5-yl}acetamide Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 10000 7.4 22.00 C Curated from the literature by BindingDB 10.1016/j.bmc.2009.03.013 10.7270/Q2G44NMS 19329331 aid1798945 Moe, ST; Thompson, AB; Smith, GM; Fredenburg, RA; Stein, RL; Jacobson, AR Absolute Science, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28912 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28912&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 25263437 58098100 ZINC40976941 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52644 [O-][N+](=O)c1ccc(cc1)-c1cc(NC(=O)CS)[nH]n1 InChI=1S/C11H10N4O3S/c16-11(6-19)12-10-5-9(13-14-10)7-1-3-8(4-2-7)15(17)18/h1-5,19H,6H2,(H2,12,13,14,16) BBOUKZWQQYAVLA-UHFFFAOYSA-N 28913 2-mercaptoacetamide, 12l::N-[3-(4-nitrophenyl)-1H-pyrazol-5-yl]-2-sulfanylacetamide Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 2900 7.4 22.00 C Curated from the literature by BindingDB 10.1016/j.bmc.2009.03.013 10.7270/Q2G44NMS 19329331 aid1798945 Moe, ST; Thompson, AB; Smith, GM; Fredenburg, RA; Stein, RL; Jacobson, AR Absolute Science, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28913 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28913&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 25263438 58098101 ZINC40846039 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52645 Cc1ccc(cc1)-c1cc(NC(=O)CS)[nH]n1 InChI=1S/C12H13N3OS/c1-8-2-4-9(5-3-8)10-6-11(15-14-10)13-12(16)7-17/h2-6,17H,7H2,1H3,(H2,13,14,15,16) MBFGEWVMHVCXLX-UHFFFAOYSA-N 28914 2-mercaptoacetamide, 12j::N-[3-(4-methylphenyl)-1H-pyrazol-5-yl]-2-sulfanylacetamide Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 21000 7.4 22.00 C Curated from the literature by BindingDB 10.1016/j.bmc.2009.03.013 10.7270/Q2G44NMS 19329331 aid1798945 Moe, ST; Thompson, AB; Smith, GM; Fredenburg, RA; Stein, RL; Jacobson, AR Absolute Science, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28914 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28914&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 25258056 58098102 ZINC40421882 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52646 COc1ccc(cc1)-c1cc(NC(=O)CS)[nH]n1 InChI=1S/C12H13N3O2S/c1-17-9-4-2-8(3-5-9)10-6-11(15-14-10)13-12(16)7-18/h2-6,18H,7H2,1H3,(H2,13,14,15,16) RQLVAEMTQGYHQN-UHFFFAOYSA-N 28915 2-mercaptoacetamide, 12k::N-[3-(4-methoxyphenyl)-1H-pyrazol-5-yl]-2-sulfanylacetamide Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 74500 7.4 22.00 C Curated from the literature by BindingDB 10.1016/j.bmc.2009.03.013 10.7270/Q2G44NMS 19329331 aid1798945 Moe, ST; Thompson, AB; Smith, GM; Fredenburg, RA; Stein, RL; Jacobson, AR Absolute Science, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28915 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28915&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 25258062 58098103 ZINC40949463 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52647 SCC(=O)Nc1cc(n[nH]1)-c1ccccc1Cl InChI=1S/C11H10ClN3OS/c12-8-4-2-1-3-7(8)9-5-10(15-14-9)13-11(16)6-17/h1-5,17H,6H2,(H2,13,14,15,16) LPVJDFOHQVRCRE-UHFFFAOYSA-N 28916 2-mercaptoacetamide, 12b::N-[3-(2-chlorophenyl)-1H-pyrazol-5-yl]-2-sulfanylacetamide Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 26000 7.4 22.00 C Curated from the literature by BindingDB 10.1016/j.bmc.2009.03.013 10.7270/Q2G44NMS 19329331 aid1798945 Moe, ST; Thompson, AB; Smith, GM; Fredenburg, RA; Stein, RL; Jacobson, AR Absolute Science, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28916 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28916&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 25263439 58098104 ZINC40949649 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52648 SCC(=O)Nc1cc(n[nH]1)-c1cccc(Cl)c1 InChI=1S/C11H10ClN3OS/c12-8-3-1-2-7(4-8)9-5-10(15-14-9)13-11(16)6-17/h1-5,17H,6H2,(H2,13,14,15,16) WOYKLAIEOXAHDK-UHFFFAOYSA-N 28917 2-mercaptoacetamide, 12g::N-[3-(3-chlorophenyl)-1H-pyrazol-5-yl]-2-sulfanylacetamide Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 5600 7.4 22.00 C Curated from the literature by BindingDB 10.1016/j.bmc.2009.03.013 10.7270/Q2G44NMS 19329331 aid1798945 Moe, ST; Thompson, AB; Smith, GM; Fredenburg, RA; Stein, RL; Jacobson, AR Absolute Science, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28917 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28917&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 25263440 58098105 ZINC40423694 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52649 FC(F)(F)c1ccccc1-c1cc(NC(=O)CS)[nH]n1 InChI=1S/C12H10F3N3OS/c13-12(14,15)8-4-2-1-3-7(8)9-5-10(18-17-9)16-11(19)6-20/h1-5,20H,6H2,(H2,16,17,18,19) ZBBUSWWGEUKZPT-UHFFFAOYSA-N 28918 2-mercaptoacetamide, 12f::2-sulfanyl-N-{3-[2-(trifluoromethyl)phenyl]-1H-pyrazol-5-yl}acetamide Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 7200 7.4 22.00 C Curated from the literature by BindingDB 10.1016/j.bmc.2009.03.013 10.7270/Q2G44NMS 19329331 aid1798945 Moe, ST; Thompson, AB; Smith, GM; Fredenburg, RA; Stein, RL; Jacobson, AR Absolute Science, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28918 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28918&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 25263441 58098106 ZINC45498480 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52650 FC(F)(F)c1cccc(c1)-c1cc(NC(=O)CS)[nH]n1 InChI=1S/C12H10F3N3OS/c13-12(14,15)8-3-1-2-7(4-8)9-5-10(18-17-9)16-11(19)6-20/h1-5,20H,6H2,(H2,16,17,18,19) QJMRYIHEVLIVKO-UHFFFAOYSA-N 28919 2-mercaptoacetamide, 12c::2-sulfanyl-N-{3-[3-(trifluoromethyl)phenyl]-1H-pyrazol-5-yl}acetamide Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 13000 7.4 22.00 C Curated from the literature by BindingDB 10.1016/j.bmc.2009.03.013 10.7270/Q2G44NMS 19329331 aid1798945 Moe, ST; Thompson, AB; Smith, GM; Fredenburg, RA; Stein, RL; Jacobson, AR Absolute Science, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28919 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28919&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search 25263442 58098107 ZINC40423732 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780 52651 ONC(=O)\C=C\c1ccc(Cl)cc1Cl InChI=1S/C9H7Cl2NO2/c10-7-3-1-6(8(11)5-7)2-4-9(13)12-14/h1-5,14H,(H,12,13)/b4-2+ LHTLDFWBUPYUDR-DUXPYHPUSA-N 23274 (2E)-3-(2,4-dichlorophenyl)-N-hydroxyprop-2-enamide::BMC173072 Compound 2::BMCL176463 Compound 2::Cinnamic hydroxamate deriv., 18 Botulinum neurotoxin type A2 [1-425] Clostridium botulinum 2400 7.4 22.00 C Curated from the literature by BindingDB 10.1016/j.bmc.2009.03.013 10.7270/Q2G44NMS 19329331 aid1798945 Moe, ST; Thompson, AB; Smith, GM; Fredenburg, RA; Stein, RL; Jacobson, AR Absolute Science, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2349&target=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23274&enzyme=Botulinum+neurotoxin+type+A2+%5B1-425%5D&column=ki&startPg=0&Increment=50&submit=Search GB4 2IMA 11708451 50091539 DB07818 ZINC14980419 1 MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLNPPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGGSTIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGYGSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPNRVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKAKSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKVINRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFTGLFEF 1E1H,2G7K,2G7N,2ILP,2IMA,2IMB,2IMC,3V0A,3V0B,3V0C,3ZUR,5V8P,5V8R,5V8U,6UI1,6UL6,6XCB,6XCC,6XCD,6XCE,6XCF Botulinum neurotoxin type A2 BXA2_CLOBJ Q45894 C1FUH9 P77780